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Abstract 
Many metabolic pathways in bacteria are modulated by metabolite-sensing 
riboswitches, which regulate gene expression at the level of transcription 
elongation or translation initiation. Riboswitches represent promising targets 
to modulate expression of genes and operons relevant for the biotechnological 
production of commercially relevant compounds. In Firmicutes, approximately 
70% of all putative and validated riboswitches (are predicted to) act 
exclusively at the transcriptional level using a termination-antitermination 
mechanism. 
   In a first attempt to interfere with purine-sensing riboswitches and 
deregulate purine metabolism in Bacillus subtilis, a set of synthetic small RNAs 
(sRNAs) targeting the purine-sensing aptamers were designed to impair ligand 
binding using rational design combined with in silico evolution. However, the 
designed sRNAs did not show any activity in vivo on the riboswitch controlling 
purine biosynthesis (pur operon riboswitch). The effect of the antisense RNA 
(asRNA) perfectly complementary to the aptamer of the pur operon riboswitch 
was also tested; The asRNA did not affect negatively expression of a 
riboswitch-regulated lacZ gene, yet similarly to the partially complementary 
sRNAs, the asRNA did not impair the downregulation exerted by the riboswitch 
in the presence of ligand. Finally, expression of the small RNAs in B. subtilis 
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was quantified, and the kinetic limitations for their hybridization with the 
aptamer and their competition with the ligand are discussed. 
   A second metabolic engineering strategy based on editing the genome of B. 
subtilis with regard to transcriptional riboswitches was investigated. Removal 
of the riboswitches that control purine biosynthesis and riboflavin biosynthesis 
in B. subtilis led to auxotrophic strains. As an alternative, a rational approach 
was developed for engineering transcriptional riboswitches independently from 
the availability of their 3D structures. This approach consists in the 
identification and deletion of a key nucleotide sequence exclusively involved in 
transcription termination without affecting formation of other secondary and 
tertiary structures potentially involved in other roles. To demonstrate the 
efficacy of the approach, it was applied to derepress the purine and the 
riboflavin biosynthetic pathways in B. subtilis. Following the proof of concept 
using specialized reporter strains, the approach was implemented into a B. 
subtilis wild-type strain employing CRISPR-Cas genome editing. The CRISPR-
Cas9 system displayed an efficiency of 61% in editing the genome, and the 
resulting purine and riboflavin production strains were characterized at the 
level of gene expression, metabolite synthesis, and growth. With a substantial 
enhancement observed at each level, the strategy established here represents 
a powerful tool for deregulating pathways modulated by transcriptional 
riboswitches. Finally, applying this strategy to derepress the purine pathway 
of an industrial riboflavin overproducing strain, with impaired growth, led to 
an increase in biomass by 53% and resulted in an enhanced total production 
of riboflavin in the culture. 
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Zusammenfassung 
Viele bakterielle Stoffwechselwege werden von RNA-Schaltern (riboswitches) 
reguliert. Diese binden bestimmte Metabolite und regulieren die Expression 
der dazugehörigen Gene durch Elongation der Transkription oder Initiation der 
Translation. RNA-Schalter sind vielversprechende Zielstrukturen im Hinblick 
auf die Regulation der Expression bestimmter Gene und 
Transkriptionseinheiten, die für die biotechnologische Herstellung kommerziell 
relevanter Produkte von Bedeutung sind. Ungefähr 70% aller erforschten und 
vermuteten RNA-Schalter in den Firmicutes agieren ausschließlich auf 
transkriptionaler Ebene und basieren auf einem Termination-Antiterminations-
Mechanismus. 
   In einem ersten Versuch die Purin-Biosynthese in Bacillus subtilis durch 
Manipulation Purin-regulierter RNA-Schalter zu deregulieren, wurden 
verschiedene synthetische kleine RNA-Moleküle (small-RNAs; sRNAs) 
eingesetzt. Diese sRNAs wurden so konstruiert, dass sie das Purin-sensitive 
Aptamer der RNA-Schalter binden und die Bindung des Purin-Liganden 
verhindern. Anders als erwartet zeigten die konstruierten sRNAs in vivo keine 
Aktivität im Hinblick auf die Expression der durch den Ziel-RNA-Schalter 
kontrollierten Purin-Biosynthesegene (pur-Operon). Darüber hinaus wurde die 
anti-sense RNA (asRNA), die komplementär zum Aptamer des pur-Operon 
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Riboswitch ist, auf ihre Wirkung hin untersucht. Diese asRNA hatte jedoch 
keinen negativen Einfluss auf die Expression der Ziel-mRNA. Außerdem hatte 
sie, vergleichbar mit den partiell komplementären sRNAs, keine Auswirkung 
auf die Regulation des RNA-Schalters. Schlussendlich wurde die Expression der 
sRNAs in B. subtilis quantifiziert. Die kinetische Limitierung bezüglich der 
Hybridisierung sRNA/Aptamer, sowie ihre kompetitiven Wechselwirkungen mit 
entsprechenden Liganden, werden diskutiert. 
   Die zweite Strategie zur Deregulierung transkriptionaler RNA-Schalter 
basiert auf der Editierung des Genoms von B. subtilis. Die Entfernung der 
(gesamten) RNA-Schalter, die die Purin- und Riboflavin-Biosynthesegene 
kontrollieren, erzeugte Purin- und Riboflavin-auxotrophe Stämme. Aus diesem 
Grund scheint die Entfernung von RNA-Schaltern keine gute Option zu sein, 
um diese Stoffwechselwege zu deregulieren. Als Alternative wurde eine 
Strategie entwickelt, mit der transkriptionale RNA-Schalter unabhängig von 
der Verfügbarkeit ihrer 3D-Struktur verändert werden können. Dieser Ansatz 
besteht aus der Identifizierung und Ausschaltung einer bestimmten 
Nukleotidsequenz, die für den Abbruch der Transkription verantwortlich ist. 
Dabei sollte jedoch die Bildung anderer relevanter Sekundär- und 
Tertiärstrukturen nicht beeinflusst werden, da diese potenziell noch andere 
Aufgaben haben. Um die Wirksamkeit dieser Strategie zu demonstrieren, 
wurde sie sowohl auf den Purin- als auch den Riboflavin-Biosyntheseweg in B. 
subtilis angewandt. Ziel war in beiden Systemen die negative Regulierung der 
jeweiligen RNA-Schalter zu unterdrücken. Diese Strategie wurde zuerst in 
einem speziellen Reporterstamm demonstriert. Danach wurde sie in einem B. 
subtilis Wildtypstamm implementiert, dessen Genom mit Hilfe von CRISPR-
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Cas9 editiert wurde. Die Genomeditierung zeigte eine Effizienz von 61%. Die 
daraus resultierenden Purin- und Riboflavin-überproduzierenden Stämme 
wurden auf den Ebenen der Genexpression, Metabolitkonzentration und des 
Wachstum untersucht. Die hier verfolgte Strategie hat auf allen untersuchten 
Ebenen zu Steigerungen geführt und stellt deshalb eine vielversprechende 
Methode zur Deregulierung von Stoffwechselwegen dar, sofern diese durch 
RNA-Schalter gesteuert werden. Angewandt auf den Purin-Stoffwechselweg 
eines wachstumslimitierten, industriellen, Riboflavin-überproduzierenden 
Produktionsstamms führte diese Strategie sogar zu einer erhöhten Produktion 
(53%) von Biomasse bei gleichzeitiger Steigerung der Riboflavin-Produktion 
im Kulturüberstand. 
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1 Introduction 
1.1 Bacterial riboswitches 
A riboswitch is a cis-acting RNA element present in the  5’-untranslated region 
(5’-UTR) of some messenger RNAs (mRNAs). Riboswitches regulate expression 
of downstream gene(s) via their ability to specifically sense metabolites or 
inorganic ions and undergo a conformational change [1-3]. At present, about 
40 different classes of riboswitches were identified, mainly in bacteria but they 
are also present in archaea, fungi, plants, and algae [4]. Bacterial riboswitches 
are involved in the regulation of several fundamental metabolic pathways such 
as the biosynthesis and transport of nucleotides, vitamins and amino acids [5]. 
In the Gram-positive bacterium Bacillus subtilis, a GRAS (generally recognized 
as safe) organism employed in a variety of biotechnological processes, at least 
2% of the genes are under riboswitch control [5]. Comparative genomics 
analyses predict that a much higher number of riboswitches, whose ligands 
are undetermined, is present in bacteria [6, 7]. Hence, these RNA molecules 
represent promising engineering targets for the overproduction of small 
molecules employing specialized prokaryotic production strains. 
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1.2 Mechanisms of action of riboswitches 
Riboswitches are RNA molecules containing an aptamer domain capable of 
specifically binding a ligand, commonly a small molecule related to the function 
of the regulated gene(s). The binding event induces a conformational change 
in the downstream structure and results in a switch from an ON to an OFF 
conformation or inversely, leading either to repression or to activation of 
downstream genes depending on the type of the riboswitch [8] (repressive or 
activating) (Fig. 1a,b or 1c,d respectively). Thereby, the system works as a 
molecular switch that can turn expression OFF or ON in response to changes 
in metabolite levels. Riboswitch modulation of gene expression can be exerted 
at the transcriptional level (Fig. 1a,c) and/or at the translational level (Fig. 
1b,d). In transcriptional riboswitches, the ligand-induced structural 
rearrangement of the nascent RNA leads to formation of a transcriptional 
terminator or antiterminator structure [9, 10], whereas in translational 
riboswitches, the structural rearrangement leads to formation of alternative 
secondary structures that modify the accessibility of the ribosomal binding site 
(RBS) [11]. 
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Figure 1 ∣ Riboswitch-mediated control of gene expression. Bacterial 
riboswitches repress or activate their genes depending on the configuration of the 
corresponding leader RNA sequence (shown by the line growing from the 5’ end). 
In response to the change of the metabolite concentration, they control 
transcription termination (a,c) or translation initiation (b,d) or both if the stem–
loop structure of the terminator also serves as a sequestor of the ribosome-binding 
site (RBS). In each case, the binding of a specific metabolite (m) to the conserved 
RNA-sensor (aptamer) domain triggers a conformational change that leads to the 
formation of an alternative RNA structure that could be a terminator (a), sequestor 
(b), antiterminator (c), or antisequestor of RBS (d). The ribosome is shown in pale 
blue. The complementary RNA regions are indicated in green and blue. SD: Shine-
Dalgarno sequence. AUG: start codon. Figure adapted from Nudler and Mironov 
(2004) [8]. 
a b
c d
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   The mode of action of transcriptional riboswitches being linked to the 
transcriptional process, researchers have proposed that their activity is 
governed by a kinetic regulation regime [12-16]. In this model, a functional 
interaction between the aptamer and the ligand is limited to the time that the 
RNA polymerase (RNAP) takes to  progress between the end of aptamer 
synthesis and when it reaches the regulatory decision point to continue or 
abort transcription at the level of the terminator. This time frame was shown 
to be too short for the ligand-binding reaction to reach thermodynamic 
equilibrium. In translational riboswitches however, the time available for 
aptamer-ligand interaction and for mRNA interrogation by the ribosome lasts 
for the lifetime of the mRNA. Consequently, the activity of riboswitches that 
act on the translational level is governed by a thermodynamic regulation 
regime [15]. 
   Approximately 70% of all putative and validated riboswitches in Firmicutes 
(are predicted to) act exclusively at the transcriptional level [11]. Despite 
differences in the structures and degrees of conformational change between 
riboswitches of different classes [17], the proposed transcription termination-
antitermination mechanism described above represents a common mode of 
action in transcriptional riboswitches [9].  
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1.3 Regulation of purine and riboflavin biosyntheses in 
Bacillus subtilis 
Metabolites derived from the riboswitch-controlled purine and riboflavin 
biosynthetic pathways, such as inosine, guanosine, riboflavin (vitamin B2), 
and folic acid (vitamin B9) are of considerable importance for a sustainable 
biomanufacturing industry, and the corresponding biotechnological production 
processes employing B. subtilis as a cell factory are well established and of 
broad interest [18]. 
   Expression of the genes responsible for de novo biosynthesis of purine and 
riboflavin is regulated by repressive transcriptional riboswitches in B. subtilis. 
The purine biosynthesis operon purEKBCSQLFMNHD [5] is controlled by a 
guanine-sensing riboswitch (pur operon riboswitch) (Fig. 2a), and the 
riboflavin biosynthesis operon ribDEAHT [10] is controlled by a flavin 
mononucleotide (FMN)-sensing riboswitch (rib operon riboswitch) (Fig. 2b). 
Notably, expression of the pur operon is subjected to an additional negative 
feedback control at the DNA level mediated by the repressor PurR [19, 20], 
which binds to the so called PurBoxes upstream of the promoter Ppur and 
affects initiation of transcription of the pur operon (Fig. 2a). Two PurBoxes 
are present, a proximal and a distal sequence (box) relatively to the promoter 
Ppur [21, 22]. PurR binding to PurBoxes is inhibited by the purine biosynthesis 
substrate phosphoribosyl-α-1-pyrophosphate (PRPP) [20], whose synthesis is 
inhibited by adenosine diphosphate (ADP) and guanosine diphosphate (GDP) 
[23]. Therefore, the repressor PurR is functional when the levels of purine 
metabolites are high. The rib operon is also controlled by a regulatory protein 
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(RibR) (Fig. 2b). Synthesis of RibR is induced in the presence of organic sulfur 
sources such as methionine and taurine [24, 25]. RibR represents a 
superordinate regulator that keeps the rib operon riboswitch in an ON state 
even in the presence of high levels of FMN. Since the growth media used in 
this study do not contain high levels of methionine or taurine, RibR-mediated 
regulation is not relevant with regard to the present work. 
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Figure 2 ∣ Regulation of the pur operon responsible for de novo 
biosynthesis of purines (a) and the rib operon responsible for de novo 
biosynthesis of riboflavin (b) in B. subtilis. 
(a) PurR repressor binding to the two PurBoxes is inhibited by PRPP, whose 
synthesis is repressed by ADP and GDP. High levels of guanine lead to the 
termination of transcription of the genes purEKBCSQLFMNHD mediated by a 
riboswitch (RS) (pur operon riboswitch). IMP inosine monophosphate, AMP 
adenosine monophosphate, XMP xanthosine monophosphate, GMP guanosine 
monophosphate, ADP adenosine diphosphate, GDP guanosine diphosphate, Prs 
phosphoribosylpyrophosphate synthetase, PurEKBCSQLFMNHD purine de novo 
biosynthesis enzymes, PurA adenylosuccinate synthetase, PurB adenylosuccinate 
lyase, GuaB IMP dehydrogenase, GuaA GMP synthetase, GuaC GMP reductase, 
Adk adenylate kinase, Gmk guanylate kinase, PupG purine nucleoside 
phosphorylase, DeoD purine nucleoside phosphorylase, HprT hypoxanthine 
phosphoribosyltransferase, Xpt xanthine phosphoribosyltransferase, Apt adenine 
phosphoribosyltransferase, GuaD guanine deaminase, AdeC adenine deaminase, 
PucABCD xanthine dehydrogenases. Ppur promoter of the pur operon. 
(b) High levels of FMN lead to the termination of transcription of the genes 
ribDEAHT mediated by a riboswitch (RS) (rib operon riboswitch). An additional 
control is provided by RibR, which locks the riboswitch ON in the presence of 
methionine and taurine. FMN flavin mononucleotide, FAD flavin adenine 
dinucleotide, RibDEAH enzymes of riboflavin de novo biosynthesis, RibC 
bifunctional flavokinase/FAD synthetase, Prib promoter of the rib operon. 
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1.4 A riboswitch-based regulon controls purine 
metabolism in Bacillus subtilis 
In addition to the pur operon riboswitch regulating expression of the purine 
biosynthetic genes, four additional purine-sensing transcriptional riboswitches 
with conserved aptamer domains were identified in B. subtilis [26]. They 
modulate transcription of genes involved in purine salvage (the xpt gene 
encoding a phosphoribosyltransferase), uptake (pbuX, pbuG, and nupG 
genes), and export (pbuE gene) (Fig. 3). The xpt and pbuX genes are 
organized in a riboswitch-regulated transcriptional unit forming the xpt-pbuX 
operon and the remaining pbuG, nupG, and pbuE genes are present as single 
genes and regulated by distinct riboswitches. Similarly to the pur operon 
riboswitch, the xpt-pbuX, pbuG, and nupG riboswitches are guanine-sensing 
repressive riboswitches, whereas the pbuE riboswitch is an adenine-sensing 
activating riboswitch [27]. Under conditions of high intracellular concentration 
of purine metabolites, the riboswitch-mediated regulation leads to a 
simultaneous repression of biosynthesis, salvage, and uptake genes while the 
exporter gene is concurrently activated. As a result of such changes, purine 
concentration decreases within the cytoplasm [28]. In addition to binding 
guanine, the xpt-pbuX riboswitch was shown to also bind in vitro xanthine and 
hypoxanthine, yet with a lower affinity (dissociation constant lower than 5 nM 
for guanine and approximately 50 nM for xanthine and hypoxanthine) [5]. 
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Figure 3 ∣ Riboswitch-mediated control of purine metabolism in B. subtilis. 
The genes involved in purine biosynthesis (purEKBCSQLFMNHD), salvage (xpt), 
and uptake (pbuX, pbuG, and nupG) are negatively regulated by a guanine-
binding riboswitch, whereas the pbuE gene encoding a hypoxanthine exporter is 
positively regulated by an adenine-binding riboswitch. Each gene(s) color 
represents a purine riboswitch-controlled transcriptional unit. As the purine 
nucleotide GTP is a precursor of riboflavin biosynthesis, the purine and the 
riboflavin metabolic pathways are directly connected. For clarity, only relevant 
purine metabolites and interconversion reactions are shown in the figure. IMP 
inosine monophosphate, AMP adenosine monophosphate, XMP xanthosine 
monophosphate, GMP guanosine monophosphate, GTP guanosine triphosphate. 
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1.5 Challenges in derepressing riboswitch-controlled 
genes 
1.5.1 Riboswitch and terminator deletions 
Deletion of the rib operon riboswitch in a riboflavin overproducing B. subtilis 
strain unexpectedly led to reduced transcript levels and lower production of 
riboflavin [29]. Furthermore, conversely to what was found in a previous 
experiment employing reporter gene fusions [9], deletion of the chromosomal 
sequence that forms the termination hairpin of the rib operon riboswitch, and 
that is partly involved in formation of the antiterminator structure, resulted in 
a decrease in transcript level and in riboflavin production similarly to the 
deletion of the full-length riboswitch [30]. This can be explained by the fact 
that beside their known metabolite-sensing function, riboswitches can be 
involved in other processes. Indeed, their 5’ end secondary and tertiary 
structures can play a role in transcript stability [31-34], interaction with 
transcription factors [24, 25], or regulation in trans of the expression of other 
messenger RNAs [35]. These considerations raise the challenge of preserving 
a protective and/or functional structure when engineering a riboswitch to 
derepress a certain pathway.  
1.5.2 Random and targeted aptamer mutagenesis 
Classical random mutants selection led to the identification of deregulated B. 
subtilis riboflavin production strains carrying mutations in the aptamer of the 
rib operon riboswitch [36]. This approach for identifying mutations that 
derepress riboswitch-controlled genes requires the availability of growth 
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reducing antimetabolites for selection. In addition, a very high number of 
mutants has to be analyzed in a time-consuming process. Targeted rational 
mutagenesis of the aptamer moiety could successfully disable a specific 
riboswitch from binding its ligand [5]. However, it can be tedious to 
concurrently preserve a functional fold, and the strategy requires the 
availability of detailed structural information about the riboswitch (i.e., its 
crystal structure). 
1.6 Small regulatory RNAs in bacteria 
Small regulatory RNAs (sRNAs) are short noncoding RNAs found in many 
bacteria to regulate gene expression post-transcriptionally by sequence-
specific base pairing with target mRNAs [37]. Similarly to regulatory RNAs in 
eukaryotes, bacterial sRNAs can be perfectly complementary to the target 
mRNA or can act with partial complementarity [38]. In bacteria, sRNAs act 
typically by pairing with 5’ ends of target mRNAs around the RBS region, 
modulating initiation of translation [39-41] and/or by directing the stability of 
target transcripts [42-44]. 
    Perfectly complementary antisense RNAs (asRNAs) are also referred to as 
cis-encoded sRNAs as they are naturally encoded on the complementary 
strand of their target gene within the same genomic locus [45-48]. The typical 
function of characterized bacterial asRNAs is to repress expression of toxic 
proteins [49, 50] but few cases were reported where asRNAs base pairing 
stabilizes the target mRNA leading to increased expression [51]. 
    Partially complementary small RNAs are also referred to as trans-encoded 
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sRNAs as they are usually located on a distinct genomic locus from their target 
gene. The partial complementarity with mRNA targets confers to this sRNA 
type the flexibility to often target multiple transcripts simultaneously [40]. The 
base pairing is initiated at the level of a seed sequence made of a minimum of 
six to eight perfectly complementary nucleotides. sRNAs with partial 
complementarity are generally expressed under specific growth conditions and 
are involved in many cellular processes in bacteria, where they act either as 
positive or as negative regulators of mRNA translation. In some cases, a sRNA 
targeting multiple mRNAs can have both positive and negative regulation 
effects depending on the mRNA target [52, 53]. The RNA chaperone Hfq is 
required for the activity of partially complementary sRNAs in proteobacterial 
species including Escherichia coli, Salmonella enterica, and Vibrio cholerae 
[54-56]. However, in Gram-positive bacteria such as Staphylococcus aureus 
and Bacillus subtilis, sRNA activity is independent from Hfq [57-60]. 
   Synthetic small regulatory RNAs were successfully used in bacteria to inhibit 
translation by targeting mRNAs at the level of the Shine-Dalgarno (SD) 
sequence, preventing thereby ribosome binding [61]. Inversely, they were 
also used as translation activators in cases where the SD sequence is 
sequestered by a cis complementary sequence as it is the case in mRNAs 
regulated by translational riboswitches. The binding of the synthetic sRNA to 
the complementary sequence in that case unmasks the RBS and promotes 
translation [62]. 
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1.7 The CRISPR-Cas9 system 
The clustered regularly interspaced short palindromic repeats (CRISPR) 
associated (Cas) systems are natural bacterial defense systems against 
invasive genetic elements [63]. The mechanism of action of the most studied 
CRISPR-Cas system, the type II CRISPR-Cas9 [64], consists in the recognition 
and the processing of foreign DNA from which twenty nucleotide fragments 
(protospacers) juxtaposing a specific three nucleotides sequence, termed 
protospacer adjacent motif (PAM), get integrated into the CRISPR array locus 
in the genome of the bacterial host [65]. These integrated fragments are then 
transcribed as parts of RNAs termed CRISPR RNAs (crRNAs). crRNAs are 
recognized by a protein-RNA complex composed of the CRISPR-associated 
nuclease Cas9 and the trans-activating CRISPR RNA (tracrRNA), which contain 
a sequence complementary to the crRNA [66]. Thereby, the crRNA serves as 
a guide to the complex for recognition and specific double strand cleavage of 
the foreign target DNA by Cas9 [67, 68] (Fig. 4). 
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Figure 4 ∣ Clustered regularly interspaced short palindromic repeats 
(CRISPR)–CRISPR-associated 9 (Cas9) targeting of DNA. Cas9 interrogates 
DNA and binds reversibly to protospacer adjacent motif (PAM) sequences with 
stabilization of Cas9 at the target occurring via formation of the trans-activating 
crRNA (tracrRNA)::CRISPR RNA (crRNA) duplex. Mature crRNA anneals to the 
target with base-pairing complementarity and tracrRNA functional modules govern 
Cas9 activity and define orthogonality. Activation of Cas9 causes simultaneous 
cleavage of each strand by the RuvC and HNH domains, represented here as black 
wedges. Figure adapted from Selle and Barrangou (2015) [69]. 
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   The system was adapted and increasingly used during the last  decade for 
editing the genome of numerous eukaryotic cell lines by expressing Cas9 and 
the CRISPR RNAs in target cells, together with the introduction of a DNA 
homology repair template containing the desired genetic modification [70, 71]. 
Instead of expressing the crRNA and the tracrRNA separately, the system was 
simplified by the fusion of the two RNAs into a chimeric single guide RNA 
(gRNA) containing the scaffold that interacts with Cas9 and the twenty 
nucleotides spacer that guides the complex and binds to the target 
chromosomal sequence [72]. The specific double strand break caused by Cas9 
in the chromosome leads to the integration of the DNA homology repair 
template into the corresponding locus by homologous recombination. 
   The system was also applied to the genome editing of some bacterial species 
including Escherichia coli, Streptococcus pneumoniae [73], and Lactobacillus 
reuteri [74], allowing markerless and precise genetic modifications with no 
prerequisites such as specific mutations or counterselection genes as it is the 
case using classical selection-counterselection tools [75]. The type II CRISPR-
Cas9 system from Streptococcus pyogenes was recently adapted for the 
genetic engineering of the B. subtilis chromosome with editing efficiencies 
ranging from 33% up to 100% depending on the technic used, the strain, the 
targeted locus and the type of genetic modification [76].  
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1.8 Objective of the work 
The present work was initiated to invent a versatile method for impairing the 
regulation exerted by transcriptional riboswitches on metabolic pathways. In 
the first chapter, the possibility of using synthetic small RNAs to prevent ligand 
binding to aptamer domains and thereby impair riboswitch regulation was 
evaluated. The strategy was investigated employing small RNAs generated by 
rational design combined with in silico evolution to target purine riboswitches 
in B. subtilis. In the second chapter, the physiological effects of riboswitch 
deletion were studied, and a rational approach for editing transcriptional 
riboswitches to activate gene expression was developed. The approach was 
applied to the metabolic engineering of the purine and the riboflavin pathways 
in B. subtilis employing the CRISPR-Cas9 technology. 
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2 Materials 
2.1 Lab equipment 
Table 1 ∣ List of used lab equipment for standard procedures. 
Device Model Manufacturer 
Autoclave Varioklav® Dampfsterilisator 
75S 
H+P Labortechnik, 
Habermoos, Germany 
Bench 
centrifuge 
Eppendorf 5415 R Eppendorf, Hamburg, 
Germany 
Centrifuge 
(30k rpm) 
Sorvall WX Ultra Thermo Fischer, Waltham, 
USA 
Centrifuge (6k 
rpm) 
Heraeus Fresco 21 Heraeus, Hanau, Germany 
Dialysis 
membrane 
Tubing-Visking size 11 Medicell Int. LTD, London, 
UK 
Electroporation 
device 
Gene Pulser® II BIO-RAD, Munich, Germany 
French Press Constant Cell Disruption 
System 
Constant System, Daventry, 
UK 
Gel 
electrophoresis 
(horizontal) 
Mini-Sub Cell GT + Wide, 
Power Pac 200, Power Pac 300 
BIO-RAD, Munich, Germany 
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Device Model Manufacturer 
Gel Imager Molecular Imager® GelDoc™ 
XR, Quantity One 1D-Analysis 
software 
BIO-RAD, Munich, Germany 
Heating block Thermomixer comfort Eppendorf, Hamburg, 
Germany 
Incubator 15 L NLF22 Bioengineering, Wald, 
Switzerland 
LC/MS-system 1200 Infinity series with 
DAD/FLD and API-ESI 6130 
Quadrupole 
Agilent Technologies, 
Waldbronn, Germany 
Optical 
microscope 
BH-2 Olympus Europe, Hamburg, 
Germany 
PCR C1,000™ Thermal Cycler, dual  BIO-RAD, Munich, Germany 
Photometer  
DNA 
quantification 
NanoVue GE Healthcare, Little 
Chalfont, UK 
Photometer  Uvikon 933 BioTek Kontron Instruments 
AG, Neufahrn 
Shaking 
incubator 
Certomat® IS Sartorius Stedim GmbH, 
Göttingen, Germany 
Sterile bench Variolab Mobilien W 90 Waldner Laboreinrichtungen 
GmbH & Co KG, Wangen, 
Germany 
Water bath IKA® HBR4 digital IKA GmbH, Staufen im 
Breisgau, Germany 
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2.2 Enzymes and chemicals 
Enzymes (Phusion Hot Start II DNA polymerase used for PCR amplification, 
FastDigest restriction enzymes, FastAP Thermosensitive Alkaline Phosphatase, 
T4 Polynucleotide Kinase and T4 DNA ligase), kits for DNA extraction and 
purification, and oligonucleotides and DNA fragments were purchased from 
Thermo Fisher Scientific (Darmstadt, Germany), unless otherwise stated. Kits 
for RNA extraction and purification were purchased from Zymo Research 
(Freiburg, Germany). Chemicals were purchased from Sigma Aldrich 
(Taufkirchen, Germany), unless otherwise stated. Xanthine, adenine, 
guanosine, riboflavin, FMN, and FAD were dissolved in dimethyl sulfoxide 
(DMSO). The antibiotics ampicillin (Amp), kanamycin (Kan), and 
spectinomycin (Spc) were dissolved in distilled water, and chloramphenicol 
(Cm) was dissolved in 95% ethanol. Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) and mannose were dissolved in distilled water. 
2.3 Growth media 
Solutions were prepared in ultrapure water and media were heat sterilized in 
an autoclave (Varioklav R 75S, H+P Labortechnik, Habermoos) before use. 
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Table 2 ∣ Lysogeny Broth (LB), pH 7.2 [77]. 
Component Final Concentration 
Tryptone 10 g L-1 
Yeast extract 5 g L-1 
NaCl 10 g L-1 
 
 
Table 3 ∣ 5x C salts stock solution for C minimal medium [78]. 
Component Amount 
KH2PO4 20 g 
K2HPO4, 3 H2O 80 g 
(NH4)2SO4 16.5 g 
H2O 1000 ml 
 
 
Table 4 ∣ III’ salts stock solution for C minimal medium [78]. 
Component Amount 
MnSO4, 4 H2O 232 mg 
MgSO4, 7 H2O 12.3 g 
ZnCl2 solution (100 mM) 12.5 ml 
H2O 1000 ml 
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Table 5 ∣ C minimal medium (CMM) [78], 3% glucose. 
Component Amount 
5x C salts solution (Table 3) 20 ml 
Tryptophan (5 mg/ml) 1 ml 
Iron Ferric Ammonium Citrate (2.2 mg/ml)a 1 ml 
III’ salts solution (Table 4) 1 ml 
Glucose 3 g 
H2O 100 ml 
aSensitive to light 
 
2.4 Buffers 
Solutions were prepared in ultrapure water. For RNA analysis, RNase-free 
water was prepared by the addition of 0.1% v/v DEPC, stirring for a minimum 
of 2 hours, and heat inactivation in the autoclave. 
 
Table 6 ∣ 10x MOPS buffer, pH 7. 
Component Amount Final concentration 
MOPS 41.9 g 200 mM 
Sodium acetate anhydrous 2.9 g 50 mM 
EDTA, 3 Na, 3 H2O 3.94 g 10 mM 
RNase-free H2O 1000 ml  
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Table 7 ∣ 20x SSC buffer, pH 7. 
Component Amount Final concentration 
NaCl 175.3 g 3 M 
Trisodium citrate dihydrate 88.2 g 300 mM 
RNase-free H2O 1000 ml  
 
 
Table 8 ∣ Maleic acid buffer, pH 7.5. 
Component Amount Final concentration 
Maleic acid 11.6 g 100 mM 
NaCl 8.8 g 150 mM 
NaOH 7.9 g 200 mM 
RNase-free H2O 1000 ml  
 
 
Table 9 ∣ Detection buffer, pH 9.5. 
Component Amount Final concentration 
Tris-HCl 7.9 g 100 mM 
NaCl 2.9 g 100 mM 
RNase-free H2O 500 ml  
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2.5 Oligonucleotides 
 
Table 10 ∣ Oligonucleotides used in this study. Restriction endonuclease sites are 
underlined. 
Name Sequence (5’-3’) 
  
   S01 CACTGGCATGCGGTCTCGTGGAAGTTACTGACGTAAGAT 
   S02 ATATCTAAGTTGCGGCCGCTGGTCTGATCGATGGGATGT 
   S03 CCGGTTTGTATTGCTTCCTCATAAGTTTTTTATTTTCTGAAAACAAAAGC 
   S04 GCTTTTGTTTTCAGAAAATAAAAAACTTATGAGGAAGCAATACAAACCGG 
   S05 AGTTCATGAAGTTTCGTCGCAGCGGAAAGACAATCTTTTAAAGAATGGAG 
   S06 TAATCTAGAAAGGCCTTATTGGCCCGAATATCATGTACAACAAATTCGTG 
   S07 ATAGGGTCGACGGCCAACGAGGCCCACCAAAGAAACTTAGCTTATCAGG 
   S08 CCGCTGCGACGAAACTTCATGAACTCACCCCCAAAATCCG 
   S09 TTTTTATTTTCTGAAAACAAAAGCATTAGAAGGTGGGGAAC 
   S10 TAATCTAGAAAGGCCTTATTGGCCCTATAATGAGCGGTAATTTCGACATC 
   S11 ATAGGGTCGACGGCCAACGAGGCCCTATTATGGTCAATGTGATTACGAAG 
   S12 CCTTCTAATGCTTTTGTTTTCAGAAAATAAAAAACTTATGAGGAAGCAATACAAA
CCG 
   S13 CAGGTCGACTATTATGGTCAATGTGATTACGAAG 
   S14 GCCTCTAGATATAATGAGCGGTAATTTCGACATC 
   S15 AGTGGTCTCTTTTTTATTTTCTGAAAACAAAAGCATTAGAAGG 
   S16 GCCTCTAGATATAATGAGCGGTAATTTCGACATC 
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Name Sequence (5’-3’) 
  
   S17 ATGGTCGACTGATTTTAACGCTGAAAGGACAG 
   S18 GCTGGTCTCTAAAAGTTTATCTTAACAACGGACATGGA 
   S19 GCTGGTCTCATTTGACGGTAAATAACAAAAGAGGGGA 
   S20 TATCTAGACGTCCTCAGGAATCGAGAGTACGGT 
   S21 ACTGTCGACGAATAGATTCATATTGGCTGGAGGT 
   S22 GCTGGTCTCTCAAAATAAAAAATTCGGGGCTTTAGGT 
   S23 ATGGTCGACGGTTAAAGTGCCTGATAACAAG 
   S24 ACTGGTCTCACAAAATTGGTTATTATAGCGATCCT 
   S25 TACGCTTGCAGCTGCGTACGCAAG 
   S26 AAACCTTGCGTACGCAGCTGCAAG 
   S27 TACGCTCATAAGTGCAATGCAGAG 
   S28 AAACCTCTGCATTGCACTTATGAG 
   S29 TACGCCCGAATTTTTTATAAATTC 
   S30 AAACGAATTTATAAAAAATTCGGG 
   S31 TCCTCCCACAACCGATTTGTGC 
   S32 TGCGTTTACTCGGCATCGCAAC 
   S33 GCAAACCATCTTATCAAATGGGAT 
   S34 AACTCATATGTGATGATATCGCTGA 
   S35 GGTTTTGACCATTTGACCGATGATT 
   S36 AATCCATGTCGGCGCTATTTGATC 
   S37 GCGTTAAATATATTCCGAAAATGAA 
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Name Sequence (5’-3’) 
  
   S38 AGCGACTGTCCAAGTGTCTG 
   S39 GCATTTGACGAAGACCTTGC 
   S40 CTGCTTTCTAACACTGTCTGTTTTG 
   S41 GGGTGCCGACATTTACGTT 
   S42 GCACATGGCGGTGTTTTT 
   S43 GAAAGCCACGGCTAACTACG 
   S44 GACAACGCTTGCCACCTAC 
   S45 DIG-CGTGCGGTTCCATTGCTCACCCATAGTCGG-DIG 
   S46 DIG-CAGCTGGCGAAAGGGGGATGTGCTGCAAGG-DIG 
   S47 DIG-TCTAGAATTGTTATCCGCTCACAATTCCAC-DIG 
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2.6 Plasmids 
 
Table 11 ∣ Plasmids used in this study. 
Name Characteristics 
Source or 
reference 
sRNA expression plasmids 
   pIDTSMART AmpR (E. coli) Integrated DNA 
Technologies 
   pT7sRNAcontrol AmpR (E. coli), PT7 sRNAcontrol This work 
   pT7sRNA30 AmpR (E. coli), PT7 sRNA30 This work 
   pT7sRNA80 AmpR (E. coli), PT7 sRNA80 This work 
   pT7sRNA110 AmpR (E. coli), PT7 sRNA110 This work 
   pT7sRNA40xpt AmpR (E. coli), PT7 sRNA40xpt This work 
   pHT01 AmpR (E. coli), CmR (B. subtilis), Pgrac [79] 
   pHTsRNArandom AmpR (E. coli), CmR (B. subtilis), Pgrac 
sRNArandom 
This work 
   pHTsRNA30 AmpR (E. coli), CmR (B. subtilis), Pgrac 
sRNA30 
This work 
   pHTsRNA70 AmpR (E. coli), CmR (B. subtilis), Pgrac 
sRNA70 
This work 
   pHTsRNA110 AmpR (E. coli), CmR (B. subtilis), Pgrac 
sRNA110 
This work 
   pHTsRNA30pur AmpR (E. coli), CmR (B. subtilis), Pgrac 
sRNA30pur 
This work 
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Name Characteristics 
Source or 
reference 
   pHTsRNA71pur AmpR (E. coli), CmR (B. subtilis), Pgrac 
sRNA71pur 
This work 
   pHTasRNApur AmpR (E. coli), CmR (B. subtilis), Pgrac 
asRNApur 
This work 
   pHTasRNAnupG AmpR (E. coli), CmR (B. subtilis), Pgrac 
asRNAnupG 
This work 
In vitro transcription plasmids 
   pPrib-luc AmpR (E. coli), PribB luc [25] 
   pPrib-RSxpt-luc AmpR (E. coli), PribB RSxpt-pbuX luc This work 
   pMA AmpR (E. coli) Thermo Fisher 
Scientific 
   pPtac-RSxpt-luc’ AmpR (E. coli), PtacI RSxpt-pbuX luc’ This work 
Integrative plasmids for the generation of reporter strains 
   pDG268 AmpR (E. coli), 3’-amyE, CmR (B. 
subtilis), PspoIIG lacZ, 5’-amyE 
[80] 
   pSG1729 AmpR (E. coli), 3’-amyE, SpcR (B. 
subtilis), Pxyl gfpmut1’, 5’-amyE 
[81] 
   pBGAB AmpR (E. coli), 3’-amyE, SpcR (B. 
subtilis), lacZ, 5’-amyE 
This work 
   pBGABpur AmpR (E. coli), 3’-amyE, SpcR (B. 
subtilis), purE’–lacZ, 5’-amyE 
This work 
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Name Characteristics 
Source or 
reference 
   pBGABxpt AmpR (E. coli), 3’-amyE, SpcR (B. 
subtilis), xpt’–lacZ, 5’-amyE 
This work 
   pBGABnupG AmpR (E. coli), 3’-amyE, SpcR (B. 
subtilis), nupG’–lacZ, 5’-amyE 
This work 
   pBGABpbuG AmpR (E. coli), 3’-amyE, SpcR (B. 
subtilis), pbuG’–lacZ, 5’-amyE 
This work 
   pBGABpbuE AmpR (E. coli), 3’-amyE, SpcR (B. 
subtilis), pbuE’–lacZ, 5’-amyE 
This work 
   pBGAB11 AmpR (E. coli), 3’-amyE, SpcR (B. 
subtilis), purE’(mPB)–lacZ, 5’-amyE 
This work 
   pBGAB12 AmpR (E. coli), 3’-amyE, SpcR (B. 
subtilis), purE’(mPB & ΔRS)–lacZ, 5’-
amyE 
This work 
   pBGAB13 AmpR (E. coli), 3’-amyE, SpcR (B. 
subtilis), purE’(mPB & eRS)–lacZ, 5’-
amyE 
This work 
CRISPR-Cas9 plasmids 
   pJOE8999 KanR (E. coli & B. subtilis), PE194ts, 
PmanP cas9, PvanP lacPOZ’-‘gRNA 
[82] 
   pPurRHT KanR (E. coli & B. subtilis), PE194ts, 
PmanP cas9, ΔpurR homology template, 
PvanP lacPOZ’-‘gRNA 
This work 
   peRSpurHT KanR (E. coli & B. subtilis), PE194ts, 
PmanP cas9, eRSpur homology 
template, PvanP lacPOZ’-‘gRNA 
This work 
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Name Characteristics 
Source or 
reference 
   peRSribHT KanR (E. coli & B. subtilis), PE194ts, 
PmanP cas9, eRSrib homology 
template, PvanP lacPOZ’-‘gRNA 
This work 
   pABpurR KanR (E. coli & B. subtilis), PE194ts, 
PmanP cas9, ΔpurR homology template, 
PvanP sgRNAΔpurR 
This work 
   pABeRSpur KanR (E. coli & B. subtilis), PE194ts, 
PmanP cas9, eRSpur homology 
template, PvanP sgRNAeRSpur 
This work 
   pABdRSpur KanR (E. coli & B. subtilis), PE194ts, 
PmanP cas9, ΔRSpur homology 
template, PvanP sgRNAΔRSpur 
This work 
   
   
   pABeRSrib KanR (E. coli & B. subtilis), PE194ts, 
PmanP cas9, eRSrib homology 
template, PvanP sgRNAeRSrib 
This work 
   pABdRSrib KanR (E. coli & B. subtilis), PE194ts, 
PmanP cas9, ΔRSrib homology 
template, PvanP sgRNAΔRSrib 
This work 
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2.7 Bacterial strains 
 
Table 12 ∣ Bacterial strains used in this study. 
Name Genotype 
Source or 
construction 
 Escherichia coli 
   DH5α F– φ80lacZΔM15 Δ(lacZYA-
argF)U169 recA1 endA1 hsdR17(rK–, 
mK+) phoA supE44 λ– thi-
1 gyrA96 relA1 
Invitrogen 
   XL10-Gold TetrΔ(mcrA)183 Δ(mcrCB-hsdSMR-
mrr)173 endA1 supE44 thi-1 recA1 
gyrA96 relA1 lac Hte [F ́ proAB 
lacIqZΔM15 Tn10 (Tetr) Amy Camr] 
Agilent 
   
   NM538 supF hsdR trpR lacY J. Altenbuchner, 
University of 
Stuttgart 
 Bacillus subtilis 
   168 trpC2 Bacillus Genetic 
Stock Center 
   BGABpur trpC2 amyE::[pBGABpur purE’–lacZ 
spc] 
pBGABpur into 168 
   BGABxpt trpC2 amyE::[pBGABxpt xpt’–lacZ 
spc] 
pBGABxpt into 168 
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Name Genotype 
Source or 
construction 
   BGABnupG trpC2 amyE::[pBGABnupG nupG’–
lacZ spc] 
pBGABnupG into 
168 
   BGABpbuG trpC2 amyE::[pBGABpbuG pbuG’–
lacZ spc] 
pBGABpbuG into 
168 
   BGABpbuE trpC2 amyE::[pBGABpbuE pbuE’–
lacZ spc] 
pBGABpbuE into 
168 
   BGAB11 trpC2 amyE::[pBGAB11 
purE’(mPB)–lacZ spc] 
pBGAB11 into 168 
   BGABempty trpC2 amyE::[pBGAB11 
purE’(mPB)–lacZ spc] pHT01 
pHT01 into 
BGAB11 
   BGABsRNArandom trpC2 amyE::[pBGAB11 
purE’(mPB)–lacZ spc] 
pHTsRNArandom 
pHTsRNArandom into 
BGAB11 
   BGABsRNA30 trpC2 amyE::[pBGAB11 
purE’(mPB)–lacZ spc] pHTsRNA30 
pHTsRNA30 into 
BGAB11 
   BGABsRNA70 trpC2 amyE::[pBGAB11 
purE’(mPB)–lacZ spc] pHTsRNA70 
pHTsRNA70 into 
BGAB11 
   BGABsRNA110 trpC2 amyE::[pBGAB11 
purE’(mPB)–lacZ spc] pHTsRNA110 
pHTsRNA110 into 
BGAB11 
   BGABsRNA30pur trpC2 amyE::[pBGAB11 
purE’(mPB)–lacZ spc] 
pHTsRNA30pur 
pHTsRNA30pur into 
BGAB11 
   BGABsRNA71pur trpC2 amyE::[pBGAB11 
purE’(mPB)–lacZ spc] 
pHTsRNA71pur 
pHTsRNA71pur into 
BGAB11 
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Name Genotype 
Source or 
construction 
   BGABasRNApur trpC2 amyE::[pBGAB11 
purE’(mPB)–lacZ spc] pHTasRNApur 
pHTasRNApur into 
BGAB11 
   BGABasRNAnupG trpC2 amyE::[pBGAB11 
purE’(mPB)–lacZ spc] 
pHTasRNAnupG 
pHTasRNAnupG 
into BGAB11 
   168sRNArandom trpC2 pHTsRNArandom pHTsRNArandom into 
168 
   BGAB12 trpC2 amyE::[pBGAB12 purE’(mPB 
ΔRS)–lacZ spc] 
pBGAB12 into 168 
   BGAB13 trpC2 amyE::[pBGAB13 purE’(mPB 
eRS)–lacZ spc] 
pBGAB13 into 168 
   BSpurR trpC2 ΔpurR pABpurR into 168 
   eBSpur2 trpC2 ΔpurR eRSpur pABeRSpur into 
BSpurR 
   BSdRSp trpC2 ΔpurR ΔRSpur pABdRSpur into 
BSpurR 
   BGAB11ΔpurR trpC2 ΔpurR amyE::[pBGAB11 
purE’(mPB)–lacZ spc] 
pBGAB11 into 
BSpurR 
   BGAB13ΔpurR trpC2 ΔpurR amyE::[pBGAB13 
purE’(mPB eRS)–lacZ spc] 
pBGAB13 into 
BSpurR 
   eBSflv trpC2 eRSrib pABeRSrib into 168 
   BSdRSr trpC2 ΔRSrib pABdRSrib into 
168 
   BGBSpurR trpC2 ΔpurR amyE::[pBGAB11 
purE’(mPB)–lacZ spc] 
pBGAB11 into 
BSpurR 
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Name Genotype 
Source or 
construction 
   BGeBSpur2 trpC2 ΔpurR eRSpur 
amyE::[pBGAB11 purE’(mPB)–lacZ 
spc] 
pBGAB11 into 
eBSpur2 
   BSRF Prib->Pveg RSrib* ribC* tkt*  M. Mack, 
Hochschule 
Mannheim  
   eBSRFpur2 Prib->Pveg RSrib* ribC* tkt* ΔpurR 
eRSpur 
pABpurR, 
pABeRSpur into 
BSRF 
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3 Methods 
3.1 Bacterial growth conditions 
Bacterial strains used in this study are listed in Table 12. 
   For plasmid propagation, E. coli was aerobically grown in lysogeny broth 
(LB) supplemented with 100 µg/ml ampicillin or 50 µg/ml kanamycin 
depending on the plasmid. B. subtilis 168 and derivatives were aerobically 
cultivated in C minimal medium supplemented with 50 µg/ml tryptophan and 
3% glucose (Table 5), unless otherwise stated. When required, antibiotics 
were added to a final concentration of 100 µg/ml for spectinomycin, 5 µg/ml 
for chloramphenicol, or 50 µg/ml for kanamycin. For induction of sRNA 
expression from pHTsRNAx plasmids, IPTG was added at inoculation to a final 
concentration of 1 mM. For activation of the pbuE riboswitch-controlled lacZ in 
the strain BGABpbuE, the medium was additionally supplemented with 3.7 mM 
adenine. For validation of the riboswitch engineering approach in reporter 
strains, the medium was additionally supplemented with 1 mM guanosine. To 
allow growth of auxotrophic strains, the medium was supplemented either with 
500 µM guanosine and 500 µM adenosine for purine auxotrophic strains, or 20 
µM riboflavin for riboflavin auxotrophic strains. Preparation of B. subtilis 
competent cells and transformation of B. subtilis were performed according to 
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the standard procedures described in Molecular Biological Methods for Bacillus 
[83]. For β-galactosidase assays, B. subtilis cells were cultivated to the mid-
exponential phase of growth, unless otherwise stated. For RNA extractions and 
riboflavin/FMN/FAD analyses, B. subtilis cells were cultivated to the early 
stationary growth phase. 
3.2 Cell lysis 
Cells were lysed employing a FastPrep-24T M 5G Instrument (MP Biomedicals, 
Santa Ana, CA, USA) using 0.2-0.3 µm glass beads and the following settings: 
8 cycles of 30 sec at 6.5 m/s with 2 min pause on ice after each cycle. 
3.3 RNA extraction 
Total RNA was extracted from B. subtilis strains using the Quick-RNA Miniprep 
Plus Kit (Zymo Research) with in-column DNase I treatment following the 
manufacturer’s protocol. Extracted RNA was quantified using NanoVue Plus 
Spectrophotometer (GE Healthcare, Freiburg, Germany) and stored at -80 °C. 
3.4 Construction of plasmids 
The sequences of oligonucleotides used in this work for the construction of 
plasmids, proof sequencing, and colony PCR are listed in Table 10, and the 
plasmids used in this study are listed in Table 11. 
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3.4.1 sRNA expression plasmids 
For the expression in vitro of synthetic sRNAs (sequences in Fig. 6, Fig. 7, and 
Fig. 8), DNA fragments corresponding to each sRNA directed upstream by the 
T7 promoter and followed by the T7 terminator sequences [84] were 
synthesized and inserted into pIDTSMART by Integrated DNA technologies 
(IDT), resulting into the set of plasmids pT7sRNAx. For sRNA expression in B. 
subtilis, the DNA fragments corresponding to each sRNA were digested from 
pT7sRNAx and inserted into a predigested pHT01 B. subtilis/E.coli shuttle 
vector using the restriction endonuclease pair XbaI/AatII, generating the set 
of plasmids pHTsRNAx. 
3.4.2 In vitro transcription plasmids 
For the in vitro transcription assay to study the activity of the xpt-pbuX 
riboswitch, a DNA fragment coding for the riboswitch sequence and flanked by 
HindIII and BamHI restriction sites was synthesized (due to the difficulty of 
PCR-amplifying riboswitch sequences that contain highly strong secondary 
structures), digested with the corresponding endonucleases, and inserted into 
a predigested pPrib-luc plasmid, resulting into pPrib-RSxpt-luc. The improved 
plasmid pPtac-RSxpt-luc’ was generated by the synthesis of the DNA fragment 
corresponding to “PtacI−xpt-pbuX riboswitch−truncated luc” and its insertion 
into the GeneArt pMA plasmid by Invitrogen (Thermo Fisher Scientific). 
3.4.3 Integrative plasmids for the generation of reporter strains 
For the construction of B. subtilis integration plasmids that generated β-
galactosidase reporter strains, the lacZ gene was PCR-amplified using the 
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primer pair S01/S02 and pDG268 as a template. The resulting DNA fragment 
was introduced into the B. subtilis/E.coli shuttle vector pSG1729 replacing a 
fragment containing the Pxyl promoter and the gene gfpmut1’ by lacZ. This 
cloning step was performed by digesting both the PCR product and pSG1729 
with the restriction endonucleases SphI/NotI followed by ligation, leading to 
pBGAB. 
   DNA fragments corresponding to the full-length regulatory regions (including 
the start codon) of the five purine riboswitch-controlled transcriptional units 
from B. subtilis (see Fig. 3) were synthesized. They were flanked by the 
restriction sites SphI upstream and BsaI downstream, the latter allowing to 
achieve scarless cloning [85]. Insertion of these synthetic DNA fragment into 
pBGAB using SphI and BsaI endonucleases generated the plasmids pBGABpur, 
pBGABxpt, pBGABnupG, pBGABpbuG, and pBGABpbuE respectively. For the 
generation of a reporter strain where the pur operon riboswitch is the sole 
modulator of LacZ expression, a DNA fragment corresponding to the purE 
regulatory sequence with inactivated PurBoxes was synthesized. PurBox 
inactivation consisted in the lack of the promoter-distal PurBox and the 
substitution C-44G in the proximal PurBox [21], which was not merely deleted 
due to a potential sequence overlap with the promoter Ppur. Introduction of 
the resulting fragment into pBGAB using the same procedure as described 
above resulted in the plasmid pBGAB11. A final DNA fragment corresponding 
to the purE regulatory sequence lacking the purine riboswitch was synthesized 
and inserted into pBGAB following the procedure described above, leading to 
the plasmid pBGAB12. Finally, the editing of the purine riboswitch in pBGAB11 
(deletion of nucleotides 181GCAATGCAGAGCGGGTAT198 within purE 5’-UTR) 
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generated the plasmid pBGAB13. This deletion was achieved by site directed 
mutagenesis using the complementary oligonucleotide pair S03/S04 and the 
QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent, Waldbronn, 
Germany). 
3.4.4 CRISPR-Cas9 plasmids 
For CRISPR-Cas9 genome editing, the repair template moieties flanking target 
sequences were amplified by PCR from B. subtilis 168 chromosomal DNA using 
the primer pairs S05/S06 and S07/S08 for purR deletion, S09/S10 and 
S11/S12 for editing the pur operon riboswitch, S15/S16 and S17/S18 for pur 
operon riboswitch deletion, S19/S20 and S21/S22 for editing the rib operon 
riboswitch, and S19/S20 and S23/S24 for rib operon riboswitch deletion. The 
resulting PCR fragments flanking purR were introduced into SmaI-linearized 
pJOE8999 using a single step CPEC reaction as described by Quan and Tian 
(2009) [86], generating pPurRHT. The repair template moieties flanking the 
target sequence for pur operon riboswitch editing were assembled using 
overlap extension PCR, and the resulting fragment was amplified using the 
primer pair S13/S14, which introduced terminal SalI and XbaI sites. The 
resulting fragment and pJOE8999 were treated with SalI/XbaI and ligation 
generated peRSpurHT. SalI/BsaI or BsaI/XbaI-treated repair template 
moieties flanking the target sequence for rib operon riboswitch editing were 
assembled and ligated to SalI/XbaI-treated pJOE8999 in one step generating 
peRSribHT. Spacer DNA sequences were generated by annealing the 
complementary oligonucleotide pairs S25/S26 for targeting purR, S27/S28 for 
targeting the pur operon riboswitch, and S29/S30 for targeting the rib operon 
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riboswitch. Thereafter, they were respectively ligated into BsaI-digested 
pPurRHT, peRSpurHT, and peRSribHT, generating the final CRISPR-Cas9 
vectors pABpurR, pABeRSpur, and pABeRSrib that were used for chromosomal 
purR deletion, pur operon riboswitch editing, and rib operon riboswitch editing, 
respectively. Final vectors for deletion of the pur operon riboswitch pABdRSpur 
and deletion of the rib operon riboswitch pABdRSrib were generated via the 
assembly and cloning of their homology templates respectively into 
pABeRSpur and pABeRSrib using SalI/BsaI/XbaI in one step as described 
above. 
3.5 In vitro transcription 
In vitro transcription assays were performed employing T7 RNA polymerase 
(Promega, Mannheim, Germany) for the production of sRNAs from linearized 
pT7sRNAx plasmids (Table 13) or employing E. coli RNA Polymerase 
Holoenzyme (New England Biolabs, Frankfurt, Germany) for transcription of 
the xpt-pbuX riboswitch−luc fusion from pPrib-RSxpt-luc (Table 14) or pPtac-
RSxpt-luc’ (Table 15). Both type of reactions were performed in the presence 
of Recombinant RNasin Ribonuclease Inhibitor (Promega) for preventing RNA 
degradation. Reaction mixtures were prepared as described in the following 
tables and incubated 12 h at 37 °C. 
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Table 13 ∣ Reaction mixture for sRNA production in vitro (Fig. 9). 
Component Amount 
Transcription Optimized 5x buffer 4 µl 
DTT, 100 mM 2 µl 
Ribonuclease Inhibitor, 100 U/µl 0.5 µl (50 units) 
rNTP mix, 10 mM 0.4 µl 
Linear pT7sRNA 500 ng 
T7 RNA Polymerase, 20 U/µl 1 µl (20 units) 
Nuclease-free water Up to 20 µl 
 
 
Table 14 ∣ Reaction mixture for in vitro transcription of the xpt-pbuX 
riboswitch−luc fusion driven by Prib (Fig. 10 & 11). 
Component Amount 
5x E. coli RNA Polymerase buffer 2 µl 
DTT, 100 mM 1 µl 
Ribonuclease Inhibitor, 100 U/µl 0.25 µl (25 units) 
rNTP mix, 10 mMa 0.2 µl 
pPrib-RSxpt-luc 250 ng 
Purified sRNA 100 ng 
E. coli RNA Polymerase, 1 U/µl 2 µl (2 units) 
Nuclease-free water Up to 10 µl 
aDifferent concentrations of the rNTP mix were tested (Fig. 11b, lanes A, B, C) 
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Table 15 ∣ Reaction mixture for in vitro transcription of the xpt-pbuX 
riboswitch−luc’ fusion driven by PtacI (Fig. 13). Conditiion 1: purified sRNAs were 
added to the riboswitch transcription reaction. Condition 2: sRNAs were co-
transcribed with the riboswitch in a combined E. coli/T7 RNA polymerases reaction. 
Component Condition 1 Condition 2 
5x E. coli RNA Polymerase buffer 2 µl 1 µl 
Transcription Optimized 5x buffer / 1 µl 
DTT, 100 mM 1 µl 1 µl 
Ribonuclease Inhibitor, 100 U/µl 0.25 µl 0.25 µl 
rNTP mix, 10 mM 0.2 µl 0.2 µl 
Linear pPtac-RSxpt-luc’ 250 ng 250 ng 
Linear pT7sRNA / 250 ng 
Purified sRNA 150-200 ng / 
Xanthine (1 mM) or DMSO 1 µl 1 µl 
E. coli RNA Polymerase, 1 U/µl 2 µl 2 µl 
T7 RNA Polymerase, 20 U/µl / 0.5 µl 
Nuclease-free water Up to 10 µl Up to 10 µl 
 
 
   Transcribed RNAs were purified using RNA Clean & Concentrator-5 kit (Zymo 
Research) with in-column DNase I treatment following the manufacturer’s 
protocol. Purified RNA was quantified using NanoVue Plus Spectrophotometer 
(GE Healthcare) and stored at -80 °C. 
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3.6 Northern Blot 
500 ng of RNA purified from in vitro transcription reactions or 10 µg total RNA 
extracted from B. subtilis was mixed with 2x RNA Gel Loading Dye (Thermo 
Fisher Scientific) and incubated 10 min at 70 °C followed by 3 min on ice. RNAs 
were then separated by denaturing agarose gel electrophoresis (1.5% agarose 
in 1x MOPS buffer (Table 6), 3.7% formaldehyde) and blotted overnight with 
20x SSC buffer (Table 7) onto a nylon membrane (Hybond-N+, Merck/Sigma 
Aldrich) by capillary force using The CP-1526 mini capillary blotter (Scie-Plas, 
Cambridge, UK).  
   RNA was crosslinked to the membrane by exposure to UV (e = 1200 x 100 
µJ/cm2). The membrane was pre-hybridized 30 min with DIG Easy Hyb solution 
(Roche) at 50 °C, then incubated overnight at the same temperature with a 
DIG Easy Hyb solution containing 20 nM double digoxigenin (DIG)-labeled DNA 
probe for hybridization. The DIG-labeled oligonucleotide S45 (Table 10) binds 
to the xpt-pbuX riboswitch, allowing thereby detection of both terminated and 
unterminated transcripts. The labeled oligonucleotide S46 binds to lacZ mRNA, 
and S47 binds to the lacO sequence transcribed upstream of sRNAs. The 
membrane was washed twice for 5 min in 2x SSC, 0.1% SDS solution at room 
temperature (RT) and twice for 15 min in 0.1x SSC, 0.1% SDS solution at 55 
°C. The membrane was rinsed with washing buffer (maleic acid buffer (Table 
8) containing 0.3% polysorbate 20) and incubated 30 min at RT in blocking 
solution (1% m/v Blocking Reagent (Roche) dissolved in maleic acid buffer) 
followed by another 30 min incubation in antibody solution (Anti-DIG-AP 150 
mU/ml (Roche) diluted 1:5000 in blocking solution). The membrane was 
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washed twice for 15 min in washing buffer and equilibrated 2-5 min in 
detection buffer (Table 9). CDP-Star solution (0.25 mM, Roche) was added to 
the membrane, and after 5 min incubation, the chemiluminescence signal was 
detected. 
3.7 RNA-Seq 
RNA samples extracted from three independent cultures of B. subtilis 168 
transformed with pHTsRNArandom were pooled in one sample to an equimolar 
ratio. The following steps of library preparation, sequencing, and data 
processing were performed by Tobias Busche (Kalinowski lab, CeBiTec, 
Bielefeld University) as described in Schaffert et al. (2019) [87]. rRNA was 
depleted using the Ribo-Zero rRNA Removal Kit for bacteria (Illumina, San 
Diego, CA, United States). Successful depletion was verified using an Agilent 
RNA 6000 Pico chip in a Bioanalyzer (Agilent, Böblingen, Germany). cDNA 
libraries were prepared following protocols from Pfeifer-Sancar et al. (2013) 
[88] and Irla et al. (2015) [89] using the TruSeq stranded mRNA kit (Illumina). 
The libraries were quantified by a DNA High Sensitivity Assay chip in the 
Bioanalyzer and sequenced on a 2 × 75 nt HiSeq 1500 run (Illumina). Raw 
reads were quality-trimmed using Trimmomatic [90]. Trimmed reads were 
mapped to the respective reference sequence using bowtie2 in the paired-end 
mode [91]. 
 
Methods 
 
 
 
 
 62 
3.8 Chromosomal integration and amylase assay 
pBGAB-derived integration vectors were linearized using the endonuclease 
ScaI, purified, and introduced into B. subtilis 168. Cells were plated on LB-
agar plates supplemented with spectinomycin and incubated overnight at 37 
°C.  
Successful double crossover integration of pBGAB-derived constructs into the 
amyE chromosomal locus of B. subtilis results into a loss of amylase activity. 
This was tested as follows. Single colonies were suspended in 20 µL sterile 
water and plated on fresh LB-agar plates supplemented with spectinomycin 
and 1 % (m/v) potato starch. Following an overnight incubation at 37°C, 
colonies were scraped from the plate with a scraper. Plates were flush with 1.1 
ml Lugol’s iodine solution. Plates corresponding to colonies with disrupted 
amyE were fully stained, whereas plates containing colonies with intact amyE 
displayed unstained halos due to the absence of stainable amylose in colony 
spots [92].  
3.9 β-galactosidase assay 
B. subtilis strains with different versions of regulatory regions from purine 
riboswitch-controlled transcriptional units fused to lacZ and integrated in the 
amyE locus were cultivated to the mid-exponential growth phase, except for 
BGAB11, BGBSpurR, and BGeBSpur2 (Fig. 28b), which were cultivated to the 
early stationary phase for assessing purine production levels during their 
complete growth cycle. Cultures were centrifuged, cells were washed, 
centrifuged again, and cell pellets suspended in buffer PM (10 mM NaH2PO4, 
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90 mM Na2HPO4, 1 mM MgSO4; pH 7.8) in which the cells were lysed. Using o-
nitrophenyl-β-D-galactopyranoside (ONPG) as a substrate, β-galactosidase 
activity was measured by monitoring ONPG hydrolysis over time. Activity 
values expressed in nanomoles of o-nitrophenol produced per minute per 
milliliter of culture (mU/ml) were normalized to the optical density values of 
corresponding cultures. 
3.10 CRISPR-Cas9 genome editing 
The CRISPR-Cas9 vectors were generated using E. coli DH5α and propagated 
using the recA-proficient strain E. coli NM538 [93] from which they were 
isolated and employed for B. subtilis transformation. B. subtilis strains 
transformed with CRISPR-Cas9 vectors were plated on LB-agar plates 
supplemented with 0.2% mannose and 50 µg/ml kanamycin. With a 
kanamycin concentration of 5 µg/ml, about 10% of the colonies corresponded 
to the original untransformed strain, indicating that the applied selective 
pressure was too low. Hence, kanamycin concentration was increased to 50 
µg/ml. More than a thousand transformants per microgram of DNA were 
obtained on every transformation plate. Plates were incubated 24 to 36 hours 
at 30 °C until colonies were visible. For plasmid curing, cells were transferred 
to LB-agar plates without kanamycin and incubated overnight at 50 °C. 
Subsequently, colonies were streaked on fresh LB-agar plates without 
kanamycin and incubated overnight at 42 °C to generate single colonies. A 
part of these colonies was transferred to LB plates containing kanamycin and 
incubated at 30 °C to test them for plasmid loss. Simultaneously, the 
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remaining colony material was transferred to 40 µL sterile water for colony 
PCR. 
   Spacer design was performed using the GPP sgRNA designer tool [94] for 
identifying spacers with high predicted ON-target activity and Cas-OFFinder 
[95] for in silico testing of selected spacer candidates for target specificity in 
B. subtilis. 
3.11 Colony PCR from B. subtilis cells 
Single colonies were suspended in 40 µL water, cells were disrupted by three 
freeze-boil cycles, samples were centrifuged, and 5 µL of the supernatant was 
used as DNA template in a 40 µL PCR reaction. Primer pairs S31/S32, S33/S34, 
and S35/S36, which anneal outside the sequences that correspond to the 
homology repair templates, were used for amplification of genomic regions 
around purR, the pur operon riboswitch, and the rib operon riboswitch 
respectively. Amplified fragments were analyzed by agarose gel 
electrophoresis and DNA sequencing. 
3.12 Quantitative RT-PCR 
1 µg of total RNA extracted from B. subtilis was used for cDNA synthesis using 
M-MLV Reverse Transcriptase (Promega) in the presence of random hexamer 
primers. The reaction was diluted 1:5 in water and used for quantitative PCR 
with PowerUp SYBR Green Master Mix (Thermo Fisher Scientific) and 0.4 µM 
of each primer. The primer pairs S37/S38, S39/S40, S41/S42, and S43/S44 
were used for amplification of cDNA corresponding to purR, purE, ribD and 
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rrnA-16S, respectively. The qPCR reaction was performed in a 10 µL final 
volume in a 384 well-plate using a Quantstudio 5 device (Applied Biosystems, 
Thermo Fisher Scientific). 
3.13 HPLC analysis of flavins 
Aliquots were removed from B. subtilis 168, eBSflv, BSRF, and eBSRFpur2 
cultures, and the cells were disrupted into the growth medium to determine 
total production of riboflavin, FMN, and FAD. Samples were treated with 10% 
(m/v) trichloroacetic acid, filtered, and flavins were separated using an Agilent 
1220 Infinity LC System (Agilent Technologies) with a reverse phase biphenyl 
column (2.6 µm particle size, 150 mm x 2.1 mm. Phenomenex, Aschaffenburg, 
Germany) at a flow rate of 0.2 ml/min. The column was equilibrated into 15% 
(v/v) methanol, 20 mM formic acid, 20 mM ammonium formate; pH 3.7. A 
gradient from 15% to 42% methanol was applied over 8 minutes during which 
absorption at 445 nm was monitored. 
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4 Results and Discussions 
4.1 Design of regulatory small RNAs (sRNAs) 
4.1.1 General design strategy 
Following a strategy based on rational design combined with in silico evolution 
to target purine-binding aptamers from B. subtilis and interfere with the 
binding of their natural ligands, a set of designer regulatory small RNAs with 
various properties were generated using a computational automated tool 
termed Ribomaker, which was manually fed with structural and rational input. 
Ribomaker is based on an algorithm that implements an evolutionary design 
strategy for bacterial riboregulation, where random mutations are selected 
according to a physicochemical model based on the minimization of free 
energies [96]. The number of iterations was set to 9000 for the design of all 
sRNAs in the present study. The length of generated sRNAs varies between 30 
and 110 nucleotides. A 30 nucleotide sequence corresponding to a bacterial 
Rho-independent terminator was added to the 3’ end of each sRNA. Structural 
constrains were fed into the program by specifying secondary structures of the 
targeted aptamers into the input data. An additional constrain was added by 
specifying an intermolecular seed sequence, which was set in the 5’ end of the 
aptamer sequence in order to enable the sRNA to start annealing with the 
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nascent aptamer as soon as the transcription process of the riboswitch starts, 
giving thereby a kinetic advantage to the sRNA over the ligand, which is only 
able to bind to the riboswitch when the aptamer is fully synthesized and folded. 
This approach is in accordance with the kinetic regulation model proposed for 
riboswitches that control expression at the transcriptional level [12-15]. To 
make sure that sRNA binding to the aptamer does not affect formation of the 
downstream structures, an additional constrain was integrated by specifying 
that the aptamer’s 3’ end sequence that is involved in the formation of the 
antiterminator (see Fig. 1a) or the terminator (see Fig. 1c) should stay 
unpaired in the aptamer-sRNA complex, except for sRNA40xpt, which was 
intended to be used as a control for this specific approach. 
4.1.2 Generation of a consensus sequence and a consensus 
structure representing the purine-binding aptamers 
Considering the high conservation of the purine aptamer domains at both the 
sequence and the structure levels, it is possible to identify and target the most 
conserved nucleotides. Therefore, a unique consensus sequence representing 
the five purine-binding aptamers from B. subtilis was generated using the 
software LocARNA [97, 98] (Fig. 5a), and its predicted secondary structure 
(Fig. 5b) was manually optimized by comparison with the available crystal 
structure of the xpt-pbuX aptamer [99] (Fig. 5c). 
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Figure 5 ∣ Generation of a consensus sequence and a consensus secondary 
structure representing the five conserved purine-sensing aptamers of B. 
subtilis. 
(a) Multiple sequence alignment of the purine aptamers showing sequence and 
structural conservation. Sequence conservation is represented by grey columns 
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under the alignment. The alignment is annotated with its consensus structure, 
which is represented as a string of dots and brackets on the top of the alignment; 
the string is well-bracketed, such that base pairs in the structure are indicated by 
corresponding opening and closing brackets. Predicted intramolecular pairings are 
highlighted with a color code; the hue shows sequence conservation and the 
saturation shows structural conservation. Alignment generated using the LocARNA 
program. Predicted consensus structure in LocARNA is generated by the tool 
RNAalifold [100] of the Vienna Package [101]. 
(b) 2D layout of the consensus secondary structure of purine aptamers alignment 
as predicted by RNAalifold. Base pairs are colored using the same color code as in 
(a). Per alignment position, the set of nucleotides with frequency higher than 
average are represented using IUPAC ambiguity codes for nucleotides. 
(c) Secondary structure of the xpt–pbuX aptamer of B. subtilis confirmed by X-
ray crystallography. Nucleotides conserved in more than 90% of known guanine 
riboswitches are shown in red. The numbering is consistent with that of the full-
length mRNA. Figure adapted from Batey et al. (2008). 
(d) Final consensus sequence with an optimized consensus structure of the purine 
aptamers. The secondary structure, represented as a string of dots and brackets 
as described in (a), was optimized by comparison of the predicted consensus 
structure in (b) with the confirmed structure in (c). 
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4.1.3 Generation and validation in silico of sRNAs 
Targeting conserved nucleotides would additionally allow a multitargeting 
strategy where a single sRNA could be used to deregulate the function of all 
conserved riboswitches simultaneously. Four sRNAs (sRNA30, sRNA70, 
sRNA80, and sRNA110) were thereby designed following this strategy by 
setting the consensus sequence and structure (Fig. 5d) as targets for sRNAs 
in Ribomaker (Fig. 6a), whereas three additional sRNAs were designed to 
target specifically either the xpt-pbuX riboswitch (sRNA40xpt) or the pur operon 
riboswitch (sRNA30pur and sRNA71pur) using their individual corresponding 
aptamer sequence as a target in Ribomaker (Fig. 7a). Generated sRNAs were 
validated in silico by simulating their interaction with the aptamer target using 
the NUPACK program [102] (Fig. 6b and Fig. 7b). 
   Experimentally, the aim is to first test and compare the activity of the 
generated sRNAs in order to gain insight about the effect of different design 
parameters such as the size of sRNAs, the targeted regions in the aptamer, 
the type of target (consensus sequence vs individual aptamer), and the level 
of pairing, and to subsequently optimize the design strategy accordingly to 
generate an improved sRNA if necessary. 
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sRNA30
UUCGGGCAAGGAGUGUGAGUGUUUCUUUAGcaaagcccgccgaaaggcgggcuuuucugu
((((.((.....)).))))........(((.((((((((((....)))))))))).))).
Consensus aptamer + sRNA30
((((((((((((((....((((.....(((..............)))....))))...((
(((((.............&.)))))))....)))))))))))))).(((.((((((((((
....)))))))))).))).
hybridization free energy = -20.8 kcal/mol
Seed-based free energy = -8.4 kcal/mol
sRNA70
CGCGGCGUGACGAGUGCUGCAUGGUAGGCAAAGGGCUGCCUCAUGUCCCUGCGUUAAUUG
UGGUGUGUUUcaaagcccgccgaaaggcgggcuuuucugu 
(((.((((((((((.(..(((((..(((((......)))))))))).))).)))))..))
).)))......((((((((((....)))))))))).....
Consensus aptamer + sRNA70 
.((((((((((((....((((((.((((((((.((..((((((((((((((((((..(((
((((..............&)).))))).))).)))))...))))))).)))..)))))).
.)))).)))))).....))))).))))))).(((((((((....)))))))))......
hybridization free energy = -27.5 kcal/mol
Seed-based free energy = -7.2 kcal/mol
sRNA80
UUUCUGUGCAUCGUGCCCACUGGUACAUGCGAUACGUGGUAUUGGGCAAGAGGUUGUGGU
UGUCGGGCGCCGCCGUAAUUcaaagcccgccgaaaggcgggcuuuucugu
.......((((.(((((....)))))))))..(((((((..((.(((((..........)
)))).))..))).))))....((((((((((....)))))))))).....
Consensus aptamer + sRNA80 
.....(((((((...)))).)))..((((((((((..((....))..(((((((((((.(
(((((.((((((..((((..&.))))..((((.(((((....)))))))))....)))))
)...))))))....)))))))))))..))).)))))))....((((((((((....))))
)))))).....
hybridization free energy = -20.1 kcal/mol
Seed-based free energy = -7.2 kcal/mol
sRNA110
UAUCGGGCCUGAUCGUUGCGUACGUAGAAGAGUGUGCCGGGUUUCGGGACCGAUGCCUCG
GUUAUGCAGGGCGACUUCAUCGUCGUCUCCCUAUAGCCAUUGUGAGUGUUcaaagcccgc
cgaaaggcgggcuuuucugu 
((((((.(((((.(.(.((((((........)))))).).)..))))).))))))....(
((((((..(((((((......)))))))...))))))).............(((((((((
(....)))))))))).....
Consensus aptamer + sRNA110 
...((((((((((..(((((.(((((.((((((((...(((((((.(.(((.((.....(
(((((.............&..)))))).....)).))).)..))))))).)))))))).)
)))).)...)))).....(((((((..(((((((......)))))))...)))))))..)
))))))))).((((((((((....)))))))))).....
hybridization free energy = -22.1 kcal/mol
Seed-based free energy = -4.8 kcal/mol
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Figure 6 ∣ Generation and in silico validation of sRNAs designed using the 
consensus sequence and consensus structure of the purine-binding 
aptamers of B. subtilis. 
(a) Generation of sRNA30, sRNA70, sRNA80, and sRNA110 using Ribomaker. 
These sRNAs were designed against the consensus sequence and structure 
generated in Figure 5d to target conserved nucleotides in the purine aptamers, 
and each sRNA is theoretically able to bind to all of the five purine aptamers in B. 
subtilis. The displayed output data show the primary sequence of each sRNA, its 
secondary structure, and the secondary structure of the complex sRNA-aptamer. 
sRNAs are named after their length in number of nucleotides excluding the 
terminator sequence shown in lower case letters. Secondary structures are 
represented by a string of points and brackets, such that base pairs are indicated 
by corresponding opening and closing brackets. Calculated free energies are 
displayed for the hybridization of the whole sRNA-aptamer complex as well as for 
the hybridization of the sRNA with the corresponding seed sequence part set in 
the 5’ end of aptamer sequences.   
(b) Validation of sRNA-consensus aptamer interactions using the NUPACK 
software. Predicted MFE structures of sRNA-aptamer complexes at 30 °C are 
displayed with calculated free-energies of secondary structures. The color code 
shows the probability for each nucleotide to be in the predicted state at reaction 
equilibrium. 
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sRNA40xpt
UGCUUCCUACGCGGACCAUAUCUACGCCUGUGUGAGUAGCcaaagcccgccgaaaggcgg
gcuuuucugu
.(((.(.(((((((.............))))))).).))).((((((((((....)))))
))))).....
xpt-pbuX aptamer
AGGAACACUCAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUG
UCCGACUAUGGGUGAGCA
.....((((((((.....(((((.......)))))..........((((((.......))
))))..))))))))....
xpt-pbuX aptamer + sRNA40xpt
.((.....(((((((...((((((((((((..(((..........((((((.......))
))))....((((.((((. & .)))))))).)))..)))))))))))).)))))))....
)).(((((((((....)))))))))......
hybridization free energy = -20.9 kcal/mol
Seed-based free energy = -8.4 kcal/mol
sRNA30pur
GAUUCAACAAUUAUGUGAGGUCGUGUUUCUcaaagcccgccgaaaggcgggcuuuucugu
((((..(((....)))..)))).........((((((((((....)))))))))).....
pur operon aptamer
ACACGACCUCAUAUAAUCUUGGGAAUAUGGCCCAUAAGUUUCUACCCGGCAACCGUAAAU
UGCCGGACUAUGCAGGAAAG
......(((((((......((((.......))))...........(((((((.......)
))))))..)))).)))....
pur operon aptamer + sRNA30pur
(((((((((((((((((..((((.......))))....(((((..(((((((.......)
))))))........))))).&.........))))))))))))))))).....((((((((
((....)))))))))).....
hybridization free energy = -25.8 kcal/mol
Seed-based free energy = -18.5 kcal/mol
sRNA71pur
GUGCGAGCGGCAUAUGCUUGUGGGCCACUCCGCUUAACAUGGCGAAUGUUCCCGAGGCAU
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....((((..(((((((((.((((......((((......))))......))))))))).
..))))..)))).(((((((((....)))))))))......
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.....(((((((...)))).)))..((((((((((..((....))..(((((((((((.(
(((((.((((((..((((.. & .))))..((((.(((((....)))))))))....)))
)))...))))))....)))))))))))..))).)))))))....((((((((((....))
)))))))).....
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Figure 7 ∣ Generation and in silico validation of sRNAs targeting 
specifically the xpt-pbuX aptamer or the pur operon aptamer of B. subtilis. 
(a) Generation of sRNA40xpt, sRNA30pur, and sRNA71pur using Ribomaker. 
sRNA40xpt was designed against the sequence and confirmed structure of the xpt-
pbuX aptamer. sRNA30pur and sRNA71pur were designed against the sequence of 
the pur operon aptamer and its optimized predicted structure. The figure shows 
the primary sequence of each sRNA and aptamer, their secondary structures, and 
the secondary structure of the complex sRNA-aptamer. The terminator sequence 
at the 3’ ends of sRNAs is shown in lower case letters. Secondary structures are 
represented by a string of points and brackets, such that base pairs are indicated 
by corresponding opening and closing brackets. Calculated free energies are 
displayed for the hybridization of the whole sRNA-aptamer complex as well as for 
the hybridization of the sRNA with the corresponding seed sequence part set in 
the 5’ end of aptamer sequences. 
(b) Validation of sRNA interaction with its corresponding aptamer target using the 
NUPACK program. Predicted MFE structures of sRNA-aptamer complexes at 30 °C 
are displayed with calculated free-energies of secondary structures. The color code 
shows the probability for each nucleotide to be in the predicted state at reaction 
equilibrium. 
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4.1.4 Generation of perfectly complementary antisense RNAs 
In addition to the partly complementary sRNAs designed using Ribomaker, two 
antisense RNAs (asRNAs) were synthesized with perfect complementarity to 
the pur operon aptamer (asRNApur) or to the nupG aptamer (asRNAnupG) 
(Fig. 8), yet excluding the 3’ end sequence that is involved in formation of the 
antiterminator as described in the general design strategy section above 
(section 4.1.1). Finally, a random RNA sequence (sRNArandom) was generated 
to be used as a general negative control. 
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Figure 8 ∣	 Generation of antisense RNAs (asRNAs) perfectly 
complementary to the pur operon aptamer (upper panel) or to the nupG 
aptamer (lower panel) of B. subtilis. MFE structures of asRNA-aptamer 
complexes at 30 °C predicted using the NUPACK software, with calculated free-
energies of secondary structures. The color code shows the probability for each 
nucleotide to be in the predicted state at reaction equilibrium.  
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4.2 Expression in vitro of designed small RNAs 
DNA fragments corresponding to the designed sRNAs driven by the strong 
bacteriophage T7 promoter [84] and followed by the T7 terminator sequence 
were synthesized and inserted into the pIDTSMART plasmid (by Integrated 
DNA Technologies), generating a set of sRNA expression vectors (pT7sRNAx). 
An in vitro sRNA production test was performed for sRNA40xpt, sRNA80, and a 
control sRNA using their corresponding plasmids pT7sRNA40xpt, pT7sRNA80, 
and pT7sRNAcontrol, which were linearized using HindIII restriction site between 
the sRNA and the terminator sequence. The resulting linear plasmids were 
used in an in vitro run-off transcription assay employing the T7 RNA 
polymerase. sRNAs were successfully expressed (Fig. 9), and 0.7-1.3 µg RNA 
could be recovered from a 20 µL reaction after DNase I treatment and 
purification, allowing the direct use of purified sRNAs in further experiments in 
vitro for the evaluation of their activity. 
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Figure 9 ∣ Production in vitro of sRNAs using the bacteriophage T7 
expression system. In vitro transcription reactions with (+) or without (-) 
subsequent DNase I treatment, analyzed using denaturing RNA gel electrophoresis 
stained with ethidium bromide. The negative control (- control) lanes correspond 
to the use of a DNA template lacking the T7 promoter. LR: low-range marker 
(Riboruler Low Range RNA Ladder). HR: high-range marker (Riboruler High Range 
RNA Ladder). The size is expressed in nucleotides. Expected sizes for sRNA40xpt, 
sRNA80, and sRNAcontrol are approximately 80, 120, and 158 nucleotides, 
respectively. 
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4.3 Development of an in vitro transcription assay for 
testing sRNA activity 
To be able to directly monitor the regulatory function of purine riboswitches at 
the transcriptional level and to subsequently measure the effect of the 
designed sRNAs in the presence of purine ligand, a cell-free in vitro 
transcription assay system was developed employing the commercially 
available Escherichia coli RNA polymerase. A fusion construct was created by 
insertion of the B. subtilis xpt-pbuX riboswitch between the E. coli ribB 
promoter Prib [103] and the firefly luciferase gene luc in the plasmid pPrib-luc 
[25]. Thus, transcription of luc is modulated by the purine-sensing xpt-pbuX 
riboswitch in the resulting plasmid pPrib-RSxpt-luc. 
4.3.1 In vitro transcripts were undetectable with gel 
electrophoresis using the promoter Prib in a linear template 
The constructed vector pPrib-RSxpt-luc was linearized using the endonuclease 
SspI and used as a template in an in vitro transcription reaction in the absence 
of purine ligand. However, no detectable RNA fragment band was observed on 
an ethidium bromide-stained gel (Fig. 10). Undetectable transcripts indicate 
that the activity of the E. coli promoter Prib is too low to allow transcript 
detection without labelling and/or that Prib is a supercoiling sensitive promoter 
that is inactive in a linear DNA template. 
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Figure 10 ∣ In vitro transcription using the E. coli promoter Prib in a linear 
DNA template does not result in detectable transcripts on a denaturing 
RNA gel stained with ethidium bromide. Lane A: in vitro transcription reaction 
before treatment with DNase I. Lane B: RNA marker (Riboruler High Range RNA 
Ladder). Lane C: in vitro transcription reaction after treatment with DNase I. RS: 
xpt-pbuX riboswitch. 
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4.3.2 The terminated riboswitch is transcribed in vitro using a 
circular DNA template and detected with Northern blot 
These suggestions were investigated further by combining in vitro 
transcription using either linear or circular (supercoiled) DNA template (Fig. 
11a) with Northern blot analysis. Although the aborted transcript 
corresponding to the xpt-pbuX riboswitch could be detected in the circular but 
not in the linear template reaction (Fig. 11b. Lane A versus F), supporting 
that Prib is supercoiling sensitive, no full-length mRNA transcript 
(riboswitch−luc) could be detected despite the absence of ligand (Fig. 11b). 
This could be due to the low efficiency of E. coli RNA polymerase in transcribing 
in vitro the long 1.9 kilobase full-length mRNA and/or to the low efficiency of 
transcription termination using the circular plasmid in vitro. The reaction with 
a circular template was simultaneously performed under lower rNTPs 
concentrations (Fig. 11b. Lane B and C), as well as in the presence of sRNAs 
produced previously (see section 4.2) (Fig. 11b. Lane D and E). However, the 
absence of detectable full-length transcript prevents drawing further 
conclusions. 
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Figure 11 ∣ The terminated transcript corresponding to the xpt-pbuX 
riboswitch is detected with Northern blot but not the full-length mRNA, 
and the E. coli promoter Prib is inactive when the DNA template is 
linearized. 
(a) Agarose gel electrophoresis of the in vitro transcription template pPrib-RSxpt-
luc in its linear and circular forms. The circular plasmid was isolated from E. coli 
cells and linearized using EcoRI restriction digest. 
(b) Northern blot analysis of in vitro transcription reactions in the absence of 
purine ligand. The reactions were treated with DNase I before analysis. The DIG-
labeled DNA probe binds to a sequence within the xpt-pbuX riboswitch, which is 
present in both terminated and full-length transcripts. The terminated transcript 
was detected using the circular DNA template at rNTPs concentrations of 20 and 
200 µM, but it was not detected using the linearized template. The full-length 
transcript was not detected at all. 
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4.3.3 Optimization of the construct for transcription and detection 
of the unterminated transcript 
To improve the assay, a new plasmid construct was designed, where Prib was 
replaced by the supercoiling-insensitive hybrid E. coli promoter PtacI [104]. In 
addition, the full-length luc gene was replaced by a truncated gene (luc’) and 
followed downstream by a XhoI restriction site. Therefore, the use of the 
resulting vector pPtac-RSxpt-luc’, linearized with XhoI endonuclease, in an in 
vitro transcription run-off assay would lead to a shorter full-length transcript 
of 0.5 kb (Fig. 12) instead of the expected 1.9 kb using the former construct 
(see Fig. 11b). 
 
 
 
Figure 12 ∣ Optimization of the construct used in the in vitro transcription 
assay to perform a transcription run-off that generates a shorter 
unterminated transcript. The promoter Prib was replaced by PtacI and the luc 
gene by a truncated luc’ followed by a XhoI restriction site, which was used to 
linearize the plasmid. The DIG-labeled DNA probe binds to a sequence within the 
xpt-pbuX riboswitch, which is present in both terminated and unterminated 
transcripts. RS: xpt-pbuX riboswitch. luc’: truncated luc gene. 
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4.3.4 The xpt-pbuX riboswitch is unresponsive to xanthine in vitro 
The new construct was tested in the absence of ligand and in the presence of 
100 µM xanthine under two different experimental set up; either by directly 
adding the purified sRNAs produced previously (see section 4.2) to an in vitro 
transcription reaction based only on E. coli RNA polymerase (Fig. 13, left 
panel), or by adding the sRNA expression vectors pT7sRNAx prelinearized to 
a combined E. coli/T7 RNA polymerases-based reaction with mixed buffers 
(Fig. 13. Right panel). Using Northern blot analysis, the detection of both 
terminated (xpt-pbuX riboswitch) and unterminated run-off (xpt-pbuX 
riboswitch−luc’) transcripts was finally successful. However, the ratios 
unterminated/terminated transcripts calculated by quantification of band 
intensities show that addition of the ligand xanthine in the absence of sRNA 
did not trigger the expected downregulation of gene transcription (Fig. 13, 
lanes A vs B and F vs G). Consequently, no conclusions could be drawn about 
sRNA activity. 
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Figure 13 ∣ The terminated xpt-pbuX riboswitch and the unterminated 
run-off transcript are both transcribed using PtacI promoter and detected 
with Northern blot, but the riboswitch is unresponsive to xanthine. The in 
vitro transcription reactions were performed in the presence of 100 µM xanthine, 
except for the DMSO control reactions (Lane A and F). The reactions were treated 
with DNase I before analysis. Left; reaction performed using E. coli RNA 
polymerase in its corresponding buffer for transcription of the riboswitch−luc’ 
fusion, and purified sRNAs were directly added to the reaction. Right; reaction 
performed using E. coli and T7 RNA polymerases in a mixed buffer for transcription 
of the riboswitch−luc’ fusion and the sRNA respectively. The ratio unterminated 
(U) / terminated (T) transcripts is expressed as a percentage for each well at the 
bottom of the figure.  
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   The unresponsiveness of the riboswitch in vitro could be due to many factors, 
such as the composition of reaction buffers [105], the type of purine ligand, 
and the temperature. Furthermore, considering the kinetic regulation 
mechanism of transcriptional riboswitches [12-15], an optimal combination of 
the type of RNA polymerase, the strength of the promoter, and the 
concentration of rNTPs might be crucial for purine riboswitches to be functional 
in vitro. Considering all these uncertainties, optimization of the in vitro 
transcription assay would be highly challenging. Therefore, sRNA activity was 
directly evaluated in vivo where purine riboswitches are in their native 
functional environment. 
4.4 Establishment of a reporter system in vivo to study 
purine riboswitch regulation and test sRNA activity 
To be able to study the regulation of genes and operons controlled by the 
purine riboswitches in B. subtilis and to subsequently measure the effect of 
the designed sRNAs in vivo, five B. subtilis test strains corresponding to each 
purine riboswitch were constructed where the E. coli β-galactosidase reporter 
gene lacZ is modulated by a B. subtilis purine riboswitch directed upstream by 
its respective native promoter. Following characterization of the promoters and 
validation of the purine-triggered modulation, activity of designed sRNAs on 
purine riboswitches can be evaluated by co-expression of sRNAs under the 
control of the IPTG-inducible strong promoter Pgrac using the B. subtilis 
episomal expression vector pHT01 [79] (Fig. 14). 
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Figure 14 ∣ Construction of a reporter system to characterize purine 
riboswitches and identify functional sRNAs in B. subtilis. The five purine 
riboswitches from B. subtilis coupled to lacZ are separately integrated into the 
amyE locus of a B. subtilis strain by homologous recombination. sRNAs are 
expressed from the episomal plasmid pHT01 under the control of the strong 
promoter Pgrac. Modulation of LacZ expression is monitored via the measurement 
of β-galactosidase enzymatic activity. RS: purine riboswitch. Pnative: the native 
promoter controlling the corresponding purine riboswitch’s transcriptional unit 
(Ppur, Pxpt-pbuX, PnupG, PpbuG, or PpbuE). 
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   First, a B. subtilis integrative vector carrying the lacZ gene was constructed. 
The resulting plasmid pBGAB was then used to generate five final vectors 
where lacZ expression is under the control of the regulatory region of each 
purine riboswitch-controlled transcriptional unit. This was carried out by 
inserting in a translational fusion setup the full-length regulatory sequence 
(containing the corresponding promoter, riboswitch, plus PurBoxes for 
purEKBCSQLFMNHD, xpt-pbuX, and pbuG) upstream of lacZ employing 
scarless type IIS endonuclease-based cloning [85]. The resulting integrative 
plasmids pBGABpur, pBGABxpt, pBGABnupG, pBGABpbuG, and pBGABpbuE 
carrying lacZ fused to the regulatory sequence of the pur operon, the xpt-pbuX 
operon, the nupG gene, the pbuG gene, and the pbuE gene respectively, were 
used to incorporate each final construct into the amyE chromosomal locus of 
a B. subtilis 168 strain by Campbell-type recombination. Cells with successful 
integration were selected using antibiotic resistance, and proper integration 
into the chromosomal amyE locus was confirmed with alpha-amylase activity 
assays, resulting into the following B. subtilis reporter strains BGABpur, 
BGABxpt, BGABnupG, BGABpbuG, and BGABpbuE, which were respectively 
named after the corresponding plasmid used to generate each strain.  
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4.4.1 Characterization of the promoters that control transcription of 
purine riboswitches-regulated genes in B. subtilis 
The first step towards studying the regulation exerted by purine riboswitches 
in vivo was to experimentally characterize the promoters controlling their 
expression in B. subtilis using the β-galactosidase reporter system described 
above. Therefore, the five generated test strains were cultivated in a minimal 
medium without purine supplementation for the four strains containing 
repressive riboswitches BGABpur, BGABxpt, BGABnupG, and BGABpbuG, or in 
a minimal medium supplemented with 3.7 mM adenine for the strain 
BGABpbuE, which contains the activating adenine-binding pbuE riboswitch. 
Cell extracts were prepared and β-galactosidase activity was measured (Fig. 
15). With a β-galactosidase signal detected in each one of the samples, the 
results of the assay validate experimentally the presence of an active promoter 
upstream of each purine riboswitch. Interestingly, the intensity of the signal 
can vary greatly from one strain to another, showing that the promoters that 
control different genes and operons involved in purine metabolism and 
transport in B. subtilis can have highly different strengths. Ppur and PpbuG 
(controlling expression of the purine biosynthesis operon and the 
guanine/hypoxanthine permease, respectively) represent the strongest 
promoters and display approximately a 12-fold higher activity than the second 
strongest promoter Pxpt-pbuX (controlling expression of the xanthine 
phosphoribosyltransferase xpt and the xanthine permease pbuX) and 
approximately a 90-fold higher activity than PnupG (controlling expression of 
the purine nucleoside importer), which represents the weakest promoter. 
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Figure 15 ∣	Experimental validation and comparison of the activity of the 
promoters governing expression of the purine riboswitches-modulated 
genes and operons in B. subtilis. β-galactosidase activity measured in test 
strains containing the regulatory regions of purine riboswitch-regulated 
transcriptional units coupled to lacZ and integrated into the amyE chromosomal 
locus of B. subtilis 168. Cells were grown in a minimal medium without purine 
supplementation, except for the culture of the strain BGABpbuE (PpbuE), which 
was supplemented with 3.7 mM adenine to activate transcription. LacZ activity 
values expressed in enzyme unit per liter of culture were determined from cell 
extracts and normalized to the optical densities of corresponding cultures. The 
values represent averages ± standard deviations of data obtained from a minimum 
of two independent cultures. 
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4.4.2 Expression of LacZ in the reporter strains is strongly 
modulated in response to guanosine or adenine 
supplementation 
To assess the effect of purine metabolites on the constructed reporter systems 
in vivo, the five reporter strains were cultivated in a minimal medium with and 
without purine supplementation. The supplemented medium contained 1 mM 
guanosine for the four strains BGABpur, BGABxpt, BGABnupG, and BGABpbuG 
containing guanine-sensing riboswitches, or 3.7 mM adenine for the strain 
BGABpbuE containing the adenine-sensing riboswitch. Measurements of β-
galactosidase activity from cell extracts show that the constructed in vivo 
system is highly responsive to purine metabolites (Fig. 16). In line with the 
type of purine riboswitch and the function of regulated genes in B. subtilis, 
high guanosine levels lead to a downregulated expression of the lacZ genes 
fused to the repressive guanine-binding riboswitches (pur operon, xpt-pbuX, 
nupG, and pbuG riboswitches), which natively regulate genes involved in 
purine biosynthesis (the pur operon), salvage (the xpt gene) and uptake (the 
pbuX, nupG, and pbuG genes) in B. subtilis, whereas high adenine levels 
upregulate expression of the lacZ gene fused to the activating adenine-binding 
pbuE riboswitch, which natively regulate the pbuE gene involved in purine 
export. 
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Figure 16 ∣ LacZ expression in the generated reporter strains is highly 
responsive to purine metabolites supplementation. β-galactosidase activity 
measured in test strains containing the regulatory region of purine riboswitch-
regulated transcriptional units coupled to lacZ. Cells grown in a minimal medium 
without purine supplementation (+ DMSO) or with 1 mM guanosine supplemented 
in the cultures of BGABpur, BGABxpt, BGABnpuG, and BGABpbuG, and 3.7 mM 
adenine supplemented in the culture of BGABpbuE strain. LacZ activity values, 
expressed as a percentage of the activated state for each construct, were 
determined from cell extracts and normalized to the optical densities of the 
cultures. The values represent averages ± standard deviations of data obtained 
from a minimum of two independent cultures. 
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   With a minimum of 50% decrease in β-galactosidase activity in response to 
purine supplementation, or to its absence in the case of BGABpbuE, and over 
91% decrease for four reporter strains out of five including BGABxpt and 
BGABpbuG that display up to 99% repression, the data show that purine 
biosynthesis, salvage, and transport genes in B. subtilis are highly responsive 
to purines and tightly regulated within a broad range of expression levels. 
Regulation of the pur operon is of the highest interest for the metabolic 
engineering of purines as it encodes the twelve enzymes responsible for purine 
de novo biosynthesis in B. subtilis. The guanosine-triggered 95% 
downregulation of LacZ expression in BGABpur indicates that a 20-fold 
increase in the expression of purine biosynthetic enzymes is potentially 
achievable in B. subtilis, showing how promising it is to successfully impair the 
negative feedback modulation exerted on the purine biosynthetic operon. 
Actually, the potential increase is likely even higher than 20-fold as even in 
the absence of purine supplementation, a certain level of lacZ repression 
should be exerted by the guanine (and potentially other purine metabolites 
[5]) synthesized de novo by the strain.  
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4.4.3 Mutations of PurR binding sites (PurBoxes) lead to an 
increase in LacZ expression and allow to study the activity of 
the pur operon riboswitch 
The purine-mediated negative feedback repression of the pur operon, as well 
as the xpt-pbuX operon and the pbuG gene, is exerted by both of the PurR 
repressor and their respective riboswitch in B. subtilis (see Fig. 2a). To be able 
to exclusively measure the modulation exerted by the pur operon riboswitch, 
the two regulatory PurBoxes present in the original wild-type fusion in 
pBGABpur (see section 4.4) were mutated, leading to the plasmid pBGAB11. 
In this plasmid, the distal PurBox was deleted whereas the proximal PurBox 
was disrupted by introducing a point mutation at the level of a nucleotide that 
is conserved among all PurBoxes identified in B. subtilis (Fig. 17). This point 
mutation was shown in a previous study to abolish the activity of PurR on the 
glyA gene [21]. Integration of pBGAB11 into the B. subtilis 168 chromosome 
generated the strain BGAB11 (mutated PurBoxes in the fusion pur operon 
regulatory sequence−lacZ). 
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Figure 17 ∣ Alignment of the tandem PurBox sequences identified 
upstream of promoters governing the expression of the nine PurR-
regulated genes and operons in B. subtilis. To impair the binding of PurR to 
the PurBoxes upstream of the promoter Ppur (purE), the distal PurBox (shown in 
a red box) was fully deleted and a conserved nucleotide within the proximal PurBox 
was substituted (C−>G shown in red) in the pur operon reporter plasmid 
pBGABpur, leading to pBGAB11. Boxed sequences are individual PurBox 
sequences. Shaded positions indicate nucleotides that diverge from the 5’-
AWWWCCGAACWWTH-3’ consensus sequence as defined by Kilstrup and 
coworkers [106]. Letters in the two bottom boxes show nucleotides that are 
conserved in the tandem PurBox motif. Lightface letters indicate nucleotides that 
are conserved in eight of the nine regulatory regions, and boldface letters indicate 
nucleotides that are conserved in all of them. Figure adapted from Saxild et al. 
(2001) [21]. 
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   LacZ activity was measured using cell extracts of BGAB11 (mutated 
PurBoxes in the fusion pur operon regulatory sequence−lacZ) cultures grown 
in a minimal medium without purine supplementation or supplemented with 
1mM guanosine (Fig. 18). As a result of the impairment of PurR activity on 
the promoter Ppur, an increase in LacZ expression is observed in BGAB11 
when compared to BGABpur (wt pur operon regulatory region) both in the 
absence of purine supplementation (2.6-fold increase in LacZ activity) and in 
the presence of 1 mM supplemented guanosine (1.8-fold increase). The 
resulting response to guanosine supplementation in BGAB11, represented by 
96.6% repression, corresponds to the modulation exerted by the pur operon 
riboswitch solely, allowing to test in vivo the activity of designed sRNAs on the 
riboswitch regulating purine de novo biosynthesis in B. subtilis. 
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Figure 18 ∣ Mutations of the pur operon PurBoxes lead to an increase in 
LacZ expression and reveal the modulation exerted by the pur operon 
riboswitch. β-galactosidase activity measured in test strains containing wild-type 
(BGABpur) or mutated (BGAB11) PurBoxes in the pur operon regulatory region 
coupled to lacZ. PurBox mutations consisted in the complete removal of the distal 
PurBox and the introduction of a point mutation in the proximal PurBox (see Fig. 
17) to prevent PurR binding. Cells grown in a minimal medium without purine 
supplementation (+ DMSO) or with 1 mM supplemented guanosine. LacZ activity 
values, expressed in enzyme unit per liter of culture, were determined from cell 
extracts and normalized to the optical densities of corresponding cultures in the 
exponential phase of growth. mPB: mutated PurBoxes. The values represent 
averages ± standard deviations of data obtained from a minimum of two 
independent cultures. 
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4.5 Testing sRNAs activity on the pur operon riboswitch 
in B. subtilis reporter strains 
To evaluate the functional activity of the designed small RNAs on the pur 
operon riboswitch in B. subtilis, DNA fragments corresponding to the small 
RNAs were inserted into the B. subtilis episomal vector pHT01 [79], generating 
a set of sRNA expression plasmids (pHTsRNAx). Thereafter, the reporter strain 
BGAB11, generated and characterized in the previous section, was 
transformed with the resulting plasmids, leading to a set of test strains 
(BGABsRNAx) co-expressing a small RNA and the pur riboswitch-modulated 
LacZ reporter (see Fig. 14). 
4.5.1 Designed sRNAs are sustainably expressed in B. subtilis, but 
they have no activity on the pur operon riboswitch 
First, proper expression of different sRNAs in their corresponding test strain 
was checked at different growth phases as follows. Total RNA was extracted 
at 4, 6, and 8 hours post-inoculation from the test strains BGABsRNA30, 
BGABsRNA70, BGABsRNA71pur, and BGABsRNA110, which were cultivated in a 
minimal medium supplemented with 1 mM IPTG for the induction of sRNA 
synthesis. Thereafter, Northern blot analysis of total RNA was performed using 
labelled probes specifically targeting the sRNAs or the lacZ transcript as a 
control. The results show that the sRNAs are sustainably expressed in B. 
subtilis, with different expression levels depending on the sRNA and on the 
growth phase (Fig. 19). 
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Figure 19 ∣ Designed sRNAs are sustainably expressed in B. subtilis. 
Northern blot analysis of total RNA extracted at 4, 6, and 8 hours post-inoculation 
from B. subtilis test strains co-expressing the respective sRNA and a pur 
riboswitch-modulated LacZ. Cells were grown in a minimal medium with 1 mM 
IPTG for the induction of sRNA expression. Double digoxigenin-labeled DNA probes 
were used for detection of the sRNAs or the lacZ transcript. Expected sRNA sizes: 
approximately 90, 130, 130, and 170 nucleotides for sRNA30, sRNA70, sRNA71pur, 
and sRNA110 respectively. 
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   Following validation of the sRNA expression system, the activity of the 
designed sRNAs on the pur operon riboswitch was tested in the presence of 
high purine levels by cultivating the corresponding test strains (BGABsRNAx) 
in a minimal medium supplemented with guanosine and measuring the activity 
of LacZ, whose expression is modulated by the pur operon riboswitch. In 
addition to the control test strain BGABsRNArandom expressing a random 
sequence, an additional control strain containing the empty pHT01 vector 
(BGABempty) was included in the experiment, and it was cultivated both with 
and without purine supplementation. Comparison of LacZ activity in the test 
strains expressing the sRNAs with the control strains shows that the designed 
sRNAs do not impair the repressive function exerted by the pur operon 
riboswitch in response to purine (Fig. 20). Indeed, the designed sRNAs have 
no significant effect on the purine-binding riboswitch, which still downregulates 
LacZ expression to similar levels in the absence and in the presence of the 
designed sRNAs. The absence of activity is observed for both types of sRNAs 
with regard to the design strategy; for sRNA30, sRNA70, and sRNA110, which 
were designed against purine aptamers consensus sequence and structure 
(see Fig. 5 and Fig. 6) as well as for sRNA30pur and sRNA71pur, which were 
designed specifically against the sequence of the pur operon aptamer (see Fig. 
7). 
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Figure 20 ∣ Designed sRNAs do not impair the purine-triggered 
downregulation exerted by the pur operon riboswitch in B. subtilis. β-
galactosidase activity measured in the test strains BGABsRNAx co-expressing the 
riboswitch-modulated LacZ reporters and the sRNAs that were designed using 
either the consensus sequence and structure of the five purine aptamers (sRNA30, 
sRNA70, and sRNA110) or using specifically the sequence of the pur operon 
aptamer (sRNA30pur and sRNA70pur). Cells grown in a minimal medium 
supplemented with 1 mM guanosine. The control strain transformed with the 
empty pHT01 vector was also grown without guanosine supplementation. LacZ 
activity values, expressed in enzyme unit per liter of culture, were determined 
from cell extracts and normalized to the optical densities of corresponding 
cultures. The values represent averages ± standard deviations of data obtained 
from a minimum of two independent cultures. 
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   Although the small RNAs were designed to not bind to the aptamer’s 3’ end 
sequence that is involved in forming the antiterminator in the ON 
conformation, their binding to upstream nucleotides would affect the structure 
of the aptamer. Therefore, this strategy comes with a risk of affecting mRNA 
stability, for example by exposing an RNase site that would have otherwise 
been sterically inaccessible or protected via intra-aptamer base pairing. 
However, as the sRNA-aptamer interaction would still form complex secondary 
structures, and as different sRNAs target different regions within the aptamer, 
it is unlikely to observe mRNA degradation with all tested sRNAs. Another 
possible consequence of sRNA binding to the riboswitch could be the 
impairment of other potential interactions in trans with regulatory factors 
similarly to the characterized interaction of the aptamer of the rib operon 
riboswitch with the transcription activator RibR in B. subtilis [24, 25]. Still, 
there is no evidence for the presence of such a regulation at the level of the 
pur operon riboswitch targeted here. Additionally, no significant difference was 
measured in β-galactosidase activity between controls (empty vector and 
sRNArandom) and designed sRNA samples, indicating that the sRNAs might 
simply not be able to bind to the pur aptamer in the presence of purine.  
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4.5.2 The modulation exerted by the pur operon riboswitch is not 
impaired by the perfectly complementary antisense RNA 
neither 
Activity of the antisense RNA asRNApur on the pur operon riboswitch was 
tested in the LacZ reporter strain BGABasRNApur. Unlike the sRNAs tested 
above, asRNApur is perfectly complementary to the aptamer of the pur operon 
riboswitch (see Fig. 8). As a control, the activity of asRNAnupG was also 
parallelly tested on the pur operon riboswitch in the reporter strain 
BGABasRNAnupG; asRNAnupG being perfectly complementary to the aptamer 
of the nupG riboswitch but only partially complementary to the aptamer of the 
pur operon riboswitch. Both strains were cultivated, together with 
BGABsRNArandom expressing a random small RNA sequence, in a minimal 
medium with or without guanosine supplementation. The resulting LacZ 
activity values measured using cell extracts show that both of the perfectly 
complementary asRNApur and the partially complementary asRNAnupG do not 
affect the expression of the riboswitch-regulated LacZ, neither in the presence 
of supplemented guanosine nor in its absence (Fig. 21). The absence of effect 
of asRNApur in the absence of purine supplementation demonstrates that 
despite being fully complementary to the pur aptamer, asRNApur does not 
affect the stability of its target transcript. However, the absence of effect in 
the presence of guanosine supplementation shows that despite the perfect 
complementarity, asRNApur is not functional on the pur operon riboswitch, 
similarly to the designed partially complementary sRNAs tested in the previous 
section. 
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Figure 21 ∣ The antisense RNA perfectly complementary to the pur 
aptamer does not affect negatively the expression of target mRNA, but it 
does not impair the regulatory function exerted by the pur operon 
riboswitch. β-galactosidase activity measured in the test strains BGABasRNApur 
and BGABasRNAnupG co-expressing the pur operon riboswitch-modulated LacZ 
and asRNAs perfectly complementary to the pur aptamer (asRNApur) or to the 
nupG aptamer (asRNAnupG). The strain BGABsRNArandom expressing a random 
RNA sequence was used as a control. Cells grown in a minimal medium without 
purine supplementation (+ DMSO) or with 1 mM supplemented guanosine. LacZ 
activity values, expressed in enzyme unit per liter of culture, were determined 
from cell extracts and normalized to the optical densities of corresponding 
cultures. The values represent averages ± standard deviations of data obtained 
from a minimum of two independent cultures. 
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4.6 Kinetics of sRNA-aptamer interactions 
Considering the kinetic regulation model of transcriptional riboswitches [12-
15], kinetic requirements and limitations were evaluated for sRNAs to 
effectively compete with the ligand guanine and hybridize in a co-
transcriptional manner with the nascent pur operon aptamer. In this model, a 
functional sRNA-aptamer interaction is limited to the time that the RNA 
polymerase (RNAP) takes to transcribe the riboswitch. During this process, two 
different windows of time could be distinguished: a first window during which 
only the sRNA could bind to the nascent aptamer; it starts when the seed 
sequence is transcribed up to the moment when the aptamer moiety is fully 
synthesized and folded. During the second window of time, the sRNA competes 
with the ligand; it starts when the aptamer domain is folded and lasts until 
RNAP reaches the regulatory decision point to continue or abort transcription. 
4.6.1 Pre-folding sRNA−aptamer hybridization 
In the present design strategy, sRNAs are able to start interacting with the 
aptamer as soon as the complementary seed sequence in its 5’ end is 
transcribed. The time frame during which the ligand is not yet able to compete 
with the sRNA lasts for the time that RNAP spends to progress to the end of 
the aptamer domain, plus the time theoretically required for its folding. 
However, a recent study modeling the co-transcriptional folding kinetics of 
purine-binding aptamers showed that the ligand binding pocket structure is 
formed as soon as the aptamer domain is transcribed [16]. This limits the 
binding advantage that sRNAs have, to the time of aptamer’s transcription. 
Different studies reported a rate of transcription by bacterial RNAP ranging 
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from 15 to 90 nucleotides per second [107-112]. If we base the model on the 
slowest reported speed, the maximum time required for transcription of 
purine-binding aptamers is approximately 6 seconds. 
   Based on a recent study in which hybridization and melting rate constants 
were measured at low concentrations for oligonucleotides of various lengths 
and under various experimental conditions [113], hybridization rate constants 
for sRNA-aptamer interaction at 30 °C are estimated to be in the 104 M-1 s-1 
range at the highest. 
   Employing RNA-Seq transcriptome analysis, the expression level of the 
random sequence sRNArandom expressed by pHTsRNArandom in B. subtilis 168 was 
measured, and its proportion relatively to total mRNAs was quantified. The 
absolute concentration of total mRNAs was calculated using a total number of 
mRNAs of 10300 molecules per B. subtilis cell [114], and a cell volume of 1.13 
µm3 in the late exponential growth phase [115], resulting in an sRNA 
concentration of 1.7x10-6 M (Table 16). 
 
Table 16 ∣ Quantification of sRNA expression in B. subtilisa using RNA-Sequencing. 
 
Normalized 
reads (RPKM) 
Ratio 
sRNArandom/mRNAs 
Concentration 
(mol L-1) 
sRNArandom 165599 0.11 1.7x10-6 
Total mRNAs 1498140 1 1.5x10-5 
aB. subtilis 168 cultivated to the late exponential growth phase in LB medium.  
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   Implementing the above values of hybridization rate constant (khyb) and 
sRNA concentration in the hybridization rate equation, the fraction of aptamer 
that hybridizes with the sRNA per second is obtained: 
Hybridization rate = khyb [sRNA] [aptamer] 
Hybridization rate (M s-1) = 0.017 [aptamer] 
Assuming that sRNA and aptamer concentrations are constants, during the 6 
seconds timeframe of aptamer transcription: 
[sRNA-aptamer] = 0.1 [aptamer] 
Thereby, at the time when the aptamer becomes able to bind its ligand, the 
fraction hybridized with the sRNA is estimated to correspond to only 10% of 
total aptamer. The actual value should be even lower, as the slowest reported 
speed for bacterial RNAP was used, and it was assumed that the hybridization 
is irreversible and that reactants concentrations are constants in order to 
obtain the highest realistic approximation of the hybridized fraction. 
4.6.2 Post-folding competitive binding 
The time available for sRNAs to interact with the aptamer is typically longer 
after its folding because of RNAP pause sites present in the expression platform 
moiety of transcriptional riboswitches [13, 116-120]. The major limitation 
during this phase lies in the kinetic competition between the sRNA and the 
ligand for binding to the aptamer. Intracellular guanine concentration 
previously measured in exponentially growing E. coli is 1.9x10-4 M [121]. 
Assuming comparable guanine concentration in B. subtilis, it is two orders of 
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magnitude higher than the calculated sRNA concentration (see Table 16). 
Therefore, to be able to kinetically compete with guanine, sRNAs would require 
hybridization rate constants that are several orders of magnitude higher than 
the association rate constant of guanine. Such khyb values are likely 
unattainable for sRNA-aptamer hybridizations as the 104 M-1 s-1 range 
estimated in the previous section is even lower than the association rate 
constant of the guanine analog 7-deazaguanine binding to the xpt-pbuX 
riboswitch (2.1x105 M-1 s-1) [14]. This indicates that once the aptamer is 
folded, it is quite unlikely for sRNAs to compete effectively with guanine, 
especially at physiologically high guanine intracellular concentrations, 
conditions under which sRNAs were expected to be functional. 
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5 Conclusion 
The attempt to impair the regulation exerted by transcriptional riboswitches 
employing sRNAs was unsuccessful for the guanine-binding pur operon 
riboswitch in Bacillus subtilis. sRNA quantification and estimations of kinetic 
parameters from recent studies indicated that the reason could be a kinetic 
advantage, which guanine has over sRNAs. Similar results are anticipated for 
sRNAs targeting the FMN-binding rib operon riboswitch in B. subtilis, as both 
the concentration and the association rate constant values for FMN (5.4x10-5 
M and 4.2x105 M-1 s-1 respectively) [14, 121] are higher than the respective 
measured concentration and estimated khyb range for sRNA binding (see 
section 4.6.1). Nevertheless, the approach could be effective on other 
transcriptional riboswitches whose ligands are less abundant in the cell and/or 
that have lower association rate constants. 
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CHAPTER II.  Rational engineering of transcriptional 
riboswitches employing CRISPR-Cas9 
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6 Results and Discussions 
6.1 Structural analysis of the xpt-pbuX riboswitch from B. 
subtilis and design of a rational engineering approach 
The purine-binding riboswitch that controls transcription of the xpt-pbuX 
operon in B. subtilis is one of the most studied riboswitches at both structural 
and functional levels [5, 26, 99]. Thus, it served as a model in the present 
study to establish a rational editing approach for engineering transcriptional 
riboswitches (Fig. 22). The aim consists in keeping the riboswitch 
constitutively ON by exclusively preventing formation of the termination 
hairpin, while concurrently promoting formation of the antiterminator and 
preserving the structure. According to the structures of the ON and OFF 
conformations (Fig. 22a), this objective should be achievable via the sole 
deletion of the 3’ strand of the stem within the termination hairpin (Fig. 22a, 
red-boxed sequence). Indeed, these key nucleotides are exclusively involved 
in forming a part of the terminator element. As a consequence of their deletion, 
the unpaired 5’ strand of the former stem becomes free to interact with a 
complementary upstream sequence (Fig. 22a, sequences in blue) and to 
engage thereby into forming the antitermination fold within a largely intact 
riboswitch. To identify the target nucleotides to delete for engineering other 
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transcriptional riboswitches, secondary structures of terminator regions are 
easily predictable using RNA structure prediction programs because of the 
simple stem-loop structure of the terminator, and no further structural 
information is required. 
   The strategy was applied in separate sets of experiments to two riboswitches 
without available crystal structures and belonging to different classes; the 
guanine-binding riboswitch that controls transcription of the purine 
biosynthetic genes purEKBCSQLFMNHD (pur operon riboswitch) and the FMN-
binding riboswitch that controls transcription of the riboflavin biosynthetic 
genes ribDEAHT (rib operon riboswitch) in B. subtilis. Structures of the 
terminator regions were predicted using the NUPACK program [102] (Fig. 
22b). The identified target nucleotides are highlighted as red-boxed 
sequences within termination hairpins in Figure 22b. In the case of the pur 
operon riboswitch, 18 nucleotides were predicted to constitute the 3’ strand of 
the terminator’s stem (Fig. 22b, left panel), whereas in the case of the rib 
operon riboswitch, 14 nucleotides were identified (Fig. 22b, right panel). 
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Figure 22 ∣ A general approach for engineering transcriptional 
riboswitches to enhance gene expression. 
(a) Riboswitch-mediated modulation of transcription: a schematic representation 
of structures adopted by the wild-type xpt-pbuX riboswitch from B. subtilis in its 
OFF and ON conformations. The scheme is drawn based on the published crystal 
structure [99]. Deletion of the red-boxed sequence disrupts the formation of the 
terminator solely and releases its stem’s 5’ strand, which is then free to engage 
into forming the antiterminator via the interaction with the complementary 
sequence shown in blue. Consequently, formation of the terminator is prevented 
and the ON conformation with intact structure is promoted. The key tertiary 
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interactions that form a pseudoknot are schematically shown as three vertical lines 
(III). HX: hypoxanthine. RNA pol.: RNA polymerase. 
(b) Identification of target nucleotides to delete within terminators of 
transcriptional riboswitches. The secondary structures were predicted using the 
NUPACK program [102]. Left: predicted structure of the termination region of the 
guanine-binding pur operon riboswitch from B. subtilis. Right: predicted structure 
of the termination region of the FMN-binding rib operon riboswitch from B. subtilis. 
Red-boxed sequences represent the target nucleotides to be deleted. Bases are 
shown as dots whose colors stand for the probability to be in the displayed paired 
or unpaired state at equilibrium. Bars indicate hydrogen bonds. 
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6.2 Rational engineering of the pur operon riboswitch 
from B. subtilis, but not its deletion, alleviates gene 
repression in a reporter system 
As a proof of concept with regard to the riboswitch engineering strategy 
described in the previous section, effects of riboswitch engineering and 
riboswitch deletion were measured employing β-galactosidase reporter 
systems based on the test strains BGABpur and BGAB11, which were 
previously generated to test sRNA activity (chapter I, section 4.4.3). BGABpur 
contains the wild-type regulatory region of the pur operon (containing the two 
regulatory PurBoxes, the endogenous promoter Ppur, and the riboswitch, see 
Fig. 2a) translationally fused to the lacZ gene, whereas the PurBoxes are 
mutated in the reporter construct in BGAB11. Consequently, lacZ expression 
in BGABpur is controlled by both of the repressor PurR and the guanine-binding 
riboswitch, whereas in BGAB11, PurR activity on lacZ expression is impaired, 
and the sole activity of the riboswitch is measurable (see Fig. 18). To test the 
effect of the complete removal of the pur operon riboswitch on lacZ expression, 
the riboswitch in the plasmid pBGAB11 (used to generate the strain BGAB11) 
was deleted. Integration of the resulting construct pBGAB12 in the amyE locus 
of B. subtilis 168 generated the reporter strain BGAB12. A final plasmid was 
generated by deleting the key sequence identified in Figure 22b (left panel) 
from the riboswitch sequence in pBGAB11, resulting in the plasmid pBGAB13, 
which was then integrated in the chromosome of B. subtilis 168 to generate 
the reporter strain BGAB13. lacZ expression in BGAB13 is thus controlled by 
an engineered pur operon riboswitch.  
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   The generated reporter strains BGAB12 (mutated PurBoxes, deleted 
riboswitch) and BGAB13 (mutated PurBoxes, engineered riboswitch) were 
cultivated in a minimal medium with and without 1 mM guanosine 
supplementation. Cell extracts were prepared, and β-galactosidase activity 
was determined and compared with the activities measured in BGABpur (wild-
type regulatory region) and BGAB11 (mutated PurBoxes) (Fig. 23). LacZ 
expression decreased drastically in BGAB12 relatively to BGAB11, both in the 
absence (99.7% decrease in LacZ activity) and in the presence (94% 
decrease) of guanosine supplementation, to much lower levels than in 
BGABpur in which both the PurR repressor and the repressive riboswitch are 
active. These data show that the complete deletion of the pur operon 
riboswitch leads to drastically reduced levels of expression of the downstream 
gene, indicating that the presence of this riboswitch might be essential for 
maintaining physiological expression levels of the pur operon in B. subtilis. The 
effect of deletion of the pur operon riboswitch observed in the reporter strain 
BGAB12 is similar to the effects previously observed upon deletion of the rib 
operon riboswitch in a riboflavin overproducer B. subtilis strain [29]. In the 
presence of 1 mM supplemented guanosine, riboswitch engineering in BGAB13 
led to a 14-fold increase in LacZ activity when compared to BGAB11 and to an 
overall increase of 25-fold when compared to BGABpur. Moreover, an increase 
in LacZ activity in BGAB13 compared to BGAB11 (1.6-fold) and to BGABpur 
(4.1-fold) is observed even in the absence of guanosine supplementation. 
These data indicate that the response of the engineered riboswitch to its ligand 
was effectively reduced and demonstrate the efficiency of the developed 
approach in activating expression of riboswitch-controlled genes.  
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Figure 23 ∣ Proof of concept: effect of pur operon riboswitch deletion or 
its rational engineering on gene expression in a B. subtilis reporter 
system. The reporter strains BGABpur (wt pur operon regulatory sequence−lacZ 
fusion), BGAB11 (mutated PurBoxes), BGAB12 (mutated PurBoxes and deleted 
riboswitch), and BGAB13 (mutated PurBoxes and engineered riboswitch) were 
cultivated in a minimal medium without purine supplementation or with 1 mM 
guanosine supplemented. Cell extracts were prepared in the exponential phase of 
growth, and LacZ activity values expressed in enzyme unit per liter of culture were 
determined and normalized to the optical densities of the cultures. The change in 
LacZ expression in BGABpur upon addition of 1 mM guanosine is governed by the 
repressor PurR and the purine riboswitch, whereas this change in BGAB11 displays 
the sole activity of the riboswitch, PurR binding to the PurBoxes being impaired. 
Gene expression collapsed upon removal of the riboswitch in BGAB12. Riboswitch 
engineering in BGAB13 increased gene expression in the absence of purine 
supplementation and reactivated expression in the presence of 1 mM guanosine 
to levels even higher than in the wild-type BGABpur in the absence of purine 
supplementation. Interestingly, LacZ expression is still affected to a certain degree 
by guanosine supplementation in BGAB13. mPB: mutated PurBoxes. ΔRS: deleted 
riboswitch. eRS: engineered riboswitch. The values represent averages ± standard 
deviations of data obtained from a minimum of two independent cultures. 
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   Interestingly, comparison of LacZ activity in BGAB13 between the presence 
and the absence of guanosine supplementation shows that there is still a 
certain level of modulation of LacZ expression despite the mutation of PurR 
binding sites (distal PurBox deletion and proximal PurBox point mutation, see 
Fig. 17) and the engineering of the pur operon riboswitch, which is no more 
able to form the stem of the terminator in response to ligand binding. The 
same experiment performed in a purR deletion mutant showed similar results 
(Fig. S1), confirming that the remaining modulation of LacZ expression in 
BGAB13 does not result from PurR residual binding to the proximal PurBox. 
These data support the existence of another purine-responsive regulation, 
which is independent from PurR and from the formation of the known 
terminator of the riboswitch for the modulation of pur operon's expression in 
B. subtilis. Possible mechanisms include a ligand-influenced mRNA stability, 
metabolite-regulated interaction with transcription factors, or existence 
upstream of the targeted terminator of a second terminator that is active at 
high ligand concentrations as suggested for the rib operon riboswitch by 
Mironov et al. (2008) [30].  
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6.3 Genome editing in Bacillus subtilis employing the 
CRISPR-Cas9 system 
The previous section shows that expression of a riboswitch-regulated reporter 
gene collapses upon riboswitch deletion, whereas the implementation of the 
riboswitch engineering approach developed here leads to the expected 
upregulation of expression of a reporter gene. The following experiments were 
carried out to confirm these effects via the deletion or engineering of native 
chromosomal riboswitches and measurement of the expression of their 
regulated genes. Furthermore, the consequent effects on bacterial physiology 
were investigated to figure out whether the riboswitch engineering approach 
developed here affects the levels of metabolites in a bacterial model and 
whether it is effective in improving performance of bacterial production strains. 
Two different B. subtilis riboswitches were either deleted or engineered 
following our strategy, the pur operon riboswitch regulating purine 
biosynthesis (see Fig. 2a) and the rib operon riboswitch regulating riboflavin 
biosynthesis (see Fig. 2b). In all engineered purine-related strains generated 
here, the repressor PurR was first deleted to prevent its interference. The 
modifications of the B. subtilis 168 chromosome were carried out employing 
the CRISPR-Cas9 genome editing technology. 
   The CRISPR-Cas9 constructs generated in the present study were based on 
the pJOE8999 vector that was developed by J. Altenbuchner [82] (Fig. 24). 
pJOE8999 is a 7.8 kb plasmid that can be propagated in E. coli via the pUC 
origin of replication and in B. subtilis via the thermo-sensitive replicon PE194. 
The vector encodes a kanamycin resistance gene functional in both bacteria. 
Results and Discussions – Chapter II 
 
 
 
 
 122 
The endonuclease Cas9 from S. pyogenes is driven by the PmanP mannose-
inducible promoter and the single guide RNA (sgRNA) is constitutively 
expressed via the semisynthetic promoter PvanP*. Spacers that guide the 
complex to the chromosomal targets were cloned into the vector between BsaI 
sites as described by Altenbuchner (2016) [82]. For cloning the homology 
repair templates, the described sfiI-based ordered gene assembly in B. subtilis 
(OGAB) method did not work. Instead, a restriction site-independent method 
based on overlap extension PCR and referred to as circular polymerase 
extension cloning (CPEC) [86] was used (Fig. 25). Alternatively, when the 
overlaps contained strong secondary structures, classical cloning using the 
XbaI and SalI sites present in the vector was combined with the scarless 
Golden Gate assembly method [85]. Both strategies allowed the assembly and 
cloning of homology templates in a single step. 
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Figure 24 ∣ CRISPR-Cas9 vector pJOE8999. Physical map of the vector 
pJOE8999 containing the pUC18 minimal origin, the temperature-sensitive 
replication origin from pE194ts, a kanamycin resistance gene (kanR), cas9 under 
the control of the PmanP promoter, the sgRNA transcribed from the semisynthetic 
promoter PvanP* interrupted by the lacZ 𝛼 fragment (lacPOZ’), the 𝜆 oop terminator, 
and the T7 promoter (T7P). Figure reproduced from Altenbuchner (2016) [82].  
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Figure 25 ∣ Design and cloning strategy of the spacer and the homology 
repair template used for CRISPR/Cas9-based deletion of purR from the 
chromosome of B. subtilis. Schematic representation of B. subtilis chromosomal 
region carrying the purR gene. The PCR-amplified homology arms flanking the 
fragment to be deleted are depicted as horizontal lines in the top of the figure, 
with additional sequences representing overlaps (in green for overlaps with the 
ends of a SmaI-linearized pJOE8999, and in black for an inter-arms overlap) 
designed for CPEC assembly [86]. The sequence of the selected protospacer is 
underlined, and the protospacer adjacent motif (PAM) is depicted in bold. The 
double-stranded oligonucleotide fragment at the bottom shows the sequence of 
the spacer inserted into pJOE8999, with lowercase letters indicating the sticky 
ends fitting to the BsaI-digested sites in pJOE8999. 
  
ispE purR yabJ spoVG
tacgCTTGCAGCTGCGTACGCAAG
GAACGTCGACGCATGCGTTCcaaa
AAAGGCATCCCTCTTGCGTACGCAGCTGCAAGCTATTTGAA
TTTCCGTAGGGAGAACGCATGCGTCGACGTTCGATAAACTT
Chromosome
Spacer
Homology arms
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   Based on the described pJOE8999 vector, five constructs were generated to 
carry out the following chromosomal modifications: 1) Deletion of a 799 bp 
sequence representing most of the purR gene to abolish PurR repression of the 
promoter Ppur. 2) Deletion of an 18 bp sequence corresponding to the rational 
editing of the pur operon riboswitch (see Fig. 22). 3) Deletion of the 198 bp 
fragment representing the full-length pur operon riboswitch. 4) Deletion of a 
14 bp sequence corresponding to the rational editing of the rib operon 
riboswitch (see Fig. 22). 5) Deletion of the 258 bp fragment representing the 
full-length rib operon riboswitch. The two arms of each homology repair 
template (HT) were generated by amplification of 700-800 bp DNA fragments 
flanking each target sequence and assembled into pJOE8999, resulting 
respectively in the plasmids pPurRHT, peRSpurHT, pdRSpurHT, peRSribHT, 
and pdRSribHT. For deletion of purR, 5 spacer sequences were selected for 
their high ON-target activity out of the 67 possible spacers upstream of the 
protospacer adjacent motifs (PAM) NGG found within the target sequence. For 
the editing of the pur operon riboswitch, 2 PAM options are available within 
the targeted 18 bp sequence, and for the editing of the rib operon riboswitch, 
3 PAM options are available (Fig. 26). The spacer candidates were 
discriminated according to their predicted target site specificity in B. subtilis, 
and the most promising spacer for each of the three targeted chromosomal 
regions was synthesized and inserted into the corresponding plasmid(s) 
pPurRHT, peRSpurHT, pdRSpurHT, peRSribHT, and pdRSribHT (see above). 
The resulting final genome editing plasmids were named pABpurR (purR 
knockout vector), pABeRSpur (pur operon riboswitch editing), pABdRSpur (pur 
operon riboswitch deletion), pABeRSrib (rib operon riboswitch editing), and 
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pABdRSrib (rib operon riboswitch deletion).  
 
 
 
 
Figure 26 ∣ Design of spacers used for CRISPR/Cas9-based editing of the 
pur operon riboswitch (left) and the rib operon riboswitch (right) in the 
chromosome of B. subtilis. Alignment of wild-type chromosomal sequences in 
the regions carrying the target nucleotides to be deleted (red-boxed sequences) 
with designed spacers and homology repair templates. Chosen PAM sequences 
(NGG) are depicted in bold. 
 
 
   Engineering of purine biosynthesis in B. subtilis 168 was performed in a 
stepwise manner; first, a purR knockout strain was generated employing 
pABpurR. Then, the pur operon riboswitch in the resulting BSpurR strain was 
either edited using pABeRSpur, leading to eBSpur2 strain, or deleted using 
pABdRSpur, leading to the strain BSdRSp. Engineering of riboflavin 
biosynthesis in the strain 168 was performed by editing the rib operon 
riboswitch employing pABeRSrib, resulting in the strain eBSflv. Deletion of the 
rib operon riboswitch in 168 was carried out using pABdRSrib, resulting in the 
…GCTTCCTCATAAGTGCAATGCAGAGCGGGTATTTTTT…
…CGAAGGAGTATTCACGTTACGTCTCGCCCATAAAAAA…
CTCATAAGTGCAATGCAGAG
…GCTTCCTCATAAGTTTTTTATTTTCTGAAAA…
…CGAAGGAGTATTCAAAAATAAAAGACTTTT…
pur riboswitch rib riboswitch
…AAAGCCCCGAATTTTTTATAAATTCGGGGCTTTTTTGACG…
…TTTCGGGGCTTAAAAAATATTTAAGCCCCGAAAAAACTGC…
CCCGAATTTTTTATAAATTC
…AAAGCCCCGAATTTTTTATTTTGACGGTAAA…
...TTTCGGGGCTTAAAAAATAAAACTGCCATTT…
Chromosome
Spacer
Homology
template
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strain BSdRSr. The overall curing efficiency was 95% (out of 66 analyzed 
colonies, 3 of them still contained a plasmid following heat treatment). 57 
transformants were analyzed with regard to their target loci using colony PCR 
followed by gel electrophoresis and DNA sequencing (Fig. S2). With 35 
mutants having the expected chromosomal modification, the overall genome 
editing efficiency was 61%. 
   In J. Altenbuchner’s study [82], the efficiencies in deleting a 25.1 kb and a 
4.1 kb sequences using pJOE8999-based vectors were 89% and 97% 
respectively. The observed differences in the efficiency of genome editing 
could originate from many factors including the size of deleted sequences, 
gRNA activity, and loci accessibility. Indeed, despite an overall better 
chromosomal loci accessibility in bacteria than in eukaryotic cells, some 
regions are still more or less accessible than others for Cas9 within the 
bacterial genome [122]. 
6.4 Chromosomal deletions of the riboswitches that 
control expression of purine and riboflavin 
biosynthesis operons in B. subtilis lead to 
auxotrophic strains 
Construction of the B. subtilis strains BSdRSp (purR knockout, pur operon 
riboswitch deleted) and BSdRSr (rib operon riboswitch deleted) is described in 
the previous section. Both strains were cultured in a minimal medium and 
growth was monitored by measurement of optical densities at 600 nm over 
time (Fig. 27). After 14 hours of incubation, no growth was observed for 
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BSdRSp and BSdRSr cultures. Growth could be recovered upon 
supplementation of the medium with 500 µM guanosine and 500 µM adenosine 
in the case of BSdRSp cultures (Fig. 27a), or 20 µM riboflavin in the case of 
BSdRSr cultures (Fig. 27b), showing that BSdRSp is auxotrophic for purines 
and BSdRSr is auxotrophic for riboflavin.  
   These results are perfectly in line with the collapse in reporter gene (lacZ) 
expression observed upon deletion of the pur operon riboswitch (Fig. 23) and 
with the decrease in rib genes expression and riboflavin yield upon deletion of 
the rib operon riboswitch in a riboflavin overproducer B. subtilis strain [29]. 
Furthermore, the present data show that riboswitches represent essential 
elements for de novo biosynthesis of purines and riboflavin in B. subtilis, 
indicating that these riboswitches might not only attenuate transcription but 
are possibly involved in additional processes hypothetically related to 
transcript stability [31-34] or to interactions with protein regulators [24, 25]. 
Finally, these results demonstrate that riboswitches controlling purine and 
riboflavin biosyntheses represent excellent targets for antibacterial therapy 
[123-126] as their deletion leads to auxotrophic strains. 
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Figure 27 ∣ Deletion of riboswitches controlling purine or riboflavin 
biosynthesis leads to auxotrophic strains. 
(a) Growth of a B. subtilis strain lacking the pur operon riboswitch (BSdRSp) in a 
minimal medium, and effect of supplementation with purines (guanosine and 
adenosine). 
(b) Growth of a B. subtilis strain lacking the rib operon riboswitch (BSdRSr) in a 
minimal medium, and effect of supplementation with riboflavin. 
The values represent averages ± standard deviations of data obtained from a 
minimum of two independent cultures. 
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6.5 Riboswitch editing activates transcription of purine 
and riboflavin biosynthetic genes and enhances 
metabolite production in B. subtilis 
The following experiments were carried out to measure the effects of the 
riboswitch engineering strategy developed here on expression of regulated 
biosynthetic operons and on production of corresponding metabolites in B. 
subtilis strains edited with CRISPR-Cas9 (see section 6.3). 
   In a first analysis, relative transcript levels of the regulator gene purR and 
the first gene of the pur operon purE were measured by RT-qPCR in the strains 
BSpurR (purR knockout) and eBSpur2 (purR knockout, pur operon riboswitch 
edited) (Fig. 28a). As expected, there was no detectable purR transcript in 
both purR knockout strains, confirming the efficiency of CRISPR-Cas9 in 
deleting the purR gene (Fig. 28a, left). This deletion led to a 9.8-fold increase 
in transcript levels of purE in BSpurR relatively to the wild-type control strain 
168 (Fig. 28a, right), revealing the extent to which the repressor PurR affects 
the activity of the promoter Ppur in B. subtilis. Rational editing of the pur 
operon riboswitch led to an additional 9.2-fold increase in purE transcript levels 
in eBSpur2 when compared to BSpurR, resulting in a total enhancement of 
transcription by 90-fold in eBSpur2 relatively to the parent strain 168. These 
results demonstrate the efficacy of the implemented engineering strategy in 
activating transcription of riboswitch-controlled genes. To determine whether 
the observed increase in purE transcript levels was translated into an increase 
in the production of purine metabolites, the fusion construct pur operon 
regulatory sequence−lacZ in pBGAB11 (mutated PurBoxes, wild-type pur 
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operon riboswitch, see section 4.4.3) was employed as an intracellular genetic 
sensor that binds the purine nucleobase guanine and potentially xanthine and 
hypoxanthine [5]. Therefore, measured LacZ activity levels are inversely 
proportional to purine levels. The genetic sensor was integrated in the amyE 
locus of BSpurR and eBSpur2 and used to assess relative purine levels in the 
respective resulting strains BGBSpurR and BGeBSpur2 (Fig. 28b). In 
accordance with RT-qPCR data, the gradual decrease in LacZ activity observed 
respectively in BGBSpurR and BGeBSpur2 relatively to the unedited control 
strain BGAB11 (generated by integration of pBGAB11 into the chromosome of 
168, see section 4.4.3) indicates that intracellular levels of purine increased 
upon purR deletion and upon riboswitch editing. 
   In similar experiments, relative transcript levels of ribD, the first gene of the 
rib operon, were determined by RT-qPCR in the strain eBSflv (rib operon 
riboswitch edited) and the wild-type control strain 168. The data show that the 
transcript level of ribD is 6.7-fold higher in eBSflv relatively to its level in 168 
(Fig. 28c), showing that the rational editing of the rib operon riboswitch 
effectively activated transcription of the rib operon. Total production of 
riboflavin and its derivatives FMN and FAD was quantified in cultures of eBSflv 
and 168 strains using high performance liquid chromatography (HPLC) (Fig. 
28d). The data show that the observed 6.7-fold increase in ribD transcript 
levels was translated into a remarkable 29-fold enhancement of riboflavin 
production and also into an increase in FMN levels. This second example 
further demonstrates the potency of the developed strategy and its 
applicability to different riboswitch classes for the metabolic engineering of 
various transcriptional riboswitch-controlled pathways. 
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Figure 28 ∣ Rational editing of transcriptional riboswitches leads to 
enhanced transcript and metabolite levels in B. subtilis. The edited strains 
were grown in minimal media, and transcript and metabolite levels were 
determined by RT-qPCR and a metabolite sensor or HPLC. 
(a) Relative transcript levels of the repressor gene purR and the purine 
biosynthesis gene purE measured in the engineered strains BSpurR (purR 
knockout) and eBSpur2 (purR knockout, edited pur operon riboswitch “eRSp”) in 
comparison to the B. subtilis 168 wild-type. 
(b) Assessment of purine production in BGBSpurR and BGeBSpur2 relatively to 
the control strain BGAB11 using a purine-binding genetic sensor based on the pur 
operon riboswitch coupled to the reporter lacZ and integrated into the amyE 
chromosomal locus. Intracellular levels of guanine (and potentially xanthine and 
hypoxanthine) are inversely proportional to β-galactosidase activity. Ppur: 
endogenous promoter controlling expression of the pur operon, RS: wt pur operon 
riboswitch. RS in grey: edited endogenous pur operon riboswitch. purR grey 
arrow: deleted regulatory gene. 
(c) Relative transcript levels of the riboflavin biosynthesis gene ribD determined 
in the engineered B. subtilis strain eBSflv (edited rib operon riboswitch “eRSr”) in 
comparison to the B. subtilis 168 wild-type. 
(d) Total levels of riboflavin and its derivatives FMN and FAD in the wild-type strain 
and eBSflv. Metabolite concentrations were measured following cell lysis in the 
culture. 
The values represent averages ± standard deviations of data obtained from a 
minimum of three independent cultures. 
  
Results and Discussions – Chapter II 
 
 
 
 
 134 
6.6 purR deletion and pur operon riboswitch editing lead 
to enhanced growth of B. subtilis 168 and of the 
riboflavin overproducer BSRF 
To find out whether the genetic modifications and the resulting changes in 
metabolite levels negatively affect growth of B. subtilis, the edited strains were 
cultivated in a minimal medium and growth was monitored by measuring the 
OD at 600 nm (Fig. 29a). Interestingly, in comparison to the wild-type strain 
168, higher cell densities were reached for both purine production strains 
eBSpurR (purR knockout) and eBSpur2 (purR knockout, pur operon riboswitch 
edited), as well as for the riboflavin production strain eBSflv (rib operon 
riboswitch edited), though to a lesser extent. 
   Considering the central role of purine nucleotides in paramount cellular 
processes such as DNA replication, transcription, translation, and energy 
metabolism, it is very likely that the observed influence of purine pathway 
engineering on growth resulted from the increased intracellular purine levels 
(see Fig. 28b). This is in line with the study performed by Samant et al. (2008) 
in which they showed that nucleotide biosynthesis represents the most critical 
function for bacterial proliferation in a medium with limited levels of nucleotide 
bases [127]. Therefore, the presented modifications of the purine pathway 
(deletion of purR and editing of the pur operon riboswitch) could be beneficial 
for industrial bioprocesses based on B. subtilis. Engineering of the riboswitch 
that modulates riboflavin biosynthesis also led to enhanced growth, albeit to a 
lower degree (Fig. 29a). Similarly to purine, it is not unlikely that this effect 
resulted from the increased flavin levels (see Fig. 28d) considering the central 
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role in energy metabolism of flavoproteins, which depend on the riboflavin-
derived cofactors FMN and FAD. Nevertheless, existence of other mechanisms 
involving the riboswitch cannot be excluded. 
   With the aim of exploiting further the remarkable growth-promoting feature 
of the presented engineering of the purine pathway, purR was deleted and the 
pur operon riboswitch was edited in the industrial strain BSRF employing the 
CRISPR-Cas9 vectors pABpurR and pABeRSpur (see section 6.3) in a stepwise 
manner, leading to the strain eBSRFpur2. BSRF is a recombinant B. subtilis 
168 derivative that was engineered to overproduce riboflavin. In BSRF, the 
endogenous promoter Prib controlling expression of the rib operon is replaced 
by a strong promoter, and mutations are introduced in the rib operon 
riboswitch, in ribC (encoding the FMN producing flavokinase) and in tkt 
(encoding a transketolase of the hexose monophosphate shunt). As a side 
effect of these modifications, growth of BSRF is relatively impaired. Growth of 
the original strain BSRF, the modified strain eBSRFpur2, as well as the wild-
type strain 168 were monitored by measurement of optical densities at 600 
nm over time (Fig. 29b). Growth curves show that the introduced 
modifications (stepwise deletion of purR and editing of the pur operon 
riboswitch) boosted growth by 53% after 16 hours of incubation, allowing 
eBSRFpur2 cultures to reach even higher cell densities than the cultures of the 
wild-type strain 168. 
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Figure 29 ∣ purR deletion and pur operon riboswitch editing lead to 
enhanced growth in B. subtilis. The generated purine and riboflavin producer 
strains were grown in a minimal medium, and growth was monitored by OD 
measurement at 600 nm. 
(a) Growth of the edited strains BSpurR (purR knockout), eBSpur2 (purR 
knockout, edited pur operon riboswitch “eRSp”), and eBSflv (edited rib operon 
riboswitch “eRSr”) compared to the growth of the wild-type strain B. subtilis 168. 
The edited strains grow to a higher cell density. 
(b) Influence of the double genetic modification purR deletion and pur operon 
riboswitch editing on growth of the industrial riboflavin overproducing strain BSRF. 
The edited strain eBSRFpur2 grows to a higher cell density than BSRF, reaching 
even higher densities than the original 168 strain. 
The values represent averages ± standard errors of the means of data obtained 
from three independent cultures. *p < 0.05, Student’s t test. 
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   To determine whether the improved growth of eBSRFpur2 compared to BSRF 
was translated into an increase in riboflavin levels in the culture, total 
production of riboflavin was measured by HPLC (Fig. 30). With 44% increase 
in riboflavin levels in eBSRFpur2 cultures when compared to the cultures of 
BSRF, the increase in cell density resulted indeed in an increase in riboflavin 
production in the culture. 
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Figure 30 ∣ Effect of the enhanced growth 
of  BSRF on total production of riboflavin. 
Riboflavin concentration was measured following 
cell lysis in the culture. The values represent 
averages ± standard deviations of data obtained 
from a minimum of two independent cultures. 
Conclusions – Chapter II 
 
 
 
 
 138 
 
 
 
7 Conclusions 
Despite the characterized role of riboswitches in preventing constitutive 
expression of regulated genes and operons, the present study shows for two 
transcriptional riboswitches controlling major biosynthetic pathways in Bacillus 
subtilis that their removal from the chromosome does not result in 
transcription activation, but rather to a drastic decrease in expression that led 
to auxotrophic strains. An alternative approach based on the rational 
engineering of riboswitches was developed to alleviate transcription 
attenuation without affecting other potential structure-related functions. 
   In contrast to many other industrial strains, the strains generated from B. 
subtilis 168 wild-type have no further genetic modifications and thus can be 
employed as a starting point for further development with regard to production 
of different purine and flavin-derived compounds. Alternatively, the generated 
CRISPR-Cas9 constructs could be directly used to implement the engineering 
conducted here into existing B. subtilis industrial strains with the aim of 
increasing metabolite production and/or enhancing growth. 
   With thousands of novel riboswitch classes expected to be discovered in the 
future [4], the versatility and straightforwardness of the developed approach 
in combination with CRISPR-Cas9 genome editing make the presented 
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procedure a promising tool to rapidly engineer newly discovered transcriptional 
riboswitches in B. subtilis. Furthermore, as transcriptional riboswitches have 
common mode of actions among different species [7], the present engineering 
strategy can be implemented in other organisms. 
   Finally, considering the role that riboswitches can play in stabilizing their 
transcripts [31-34], it might be worthwhile assessing the effect of rationally 
edited riboswitches as potential stabilizing elements when introduced in the 5’ 
ends of unstable mRNAs. Such a use would have a multitude of applications in 
biotechnology and synthetic biology. 
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8 Supplementary Figures 
Figure S1. The residual responsiveness of the reporter system after 
PurBoxes mutations and pur operon riboswitch engineering (BGAB13, 
Fig. 23) is not caused by PurR residual activity. The B. subtilis mutant 
BSpurR (purR knockout) generated using CRISPR-Cas9 (section 6.3) was used 
to generate new reporter strains where it is sure that PurR activity is totally 
abolished unlike in the wild-type-based reporter strains BGAB11 and BGAB13 
previously used in Figure 23 (where the PurBoxes were mutated but PurR was 
present in the cell and the possibility of its residual binding to the point-
mutated proximal PurBox could not be excluded). Integration of the reporter 
plasmids pBGAB11 (mutated PurBoxes, wild-type pur operon riboswitch) and 
pBGAB13 (mutated PurBoxes, engineered pur operon riboswitch) in the 
chromosome of BSpurR resulted into BGAB11∆purR and BGAB13∆purR 
respectively. The resulting strains were cultivated in a minimal medium 
without purine supplementation or with 1 mM guanosine supplemented. Cell 
extracts were prepared in the exponential phase of growth, and LacZ activity 
values expressed in enzyme unit per liter of culture  were determined and 
normalized to the optical densities of the cultures. A 16-fold increase in LacZ 
expression was measured upon the engineering of the riboswitch (LacZ activity 
in BGAB13∆purR compared to the activity in BGAB11∆purR) in the presence 
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of supplemented guanosine and a 1.8-fold increase was measured in the 
absence of supplementation. These results are similar to the previous data 
measured using BGAB11 and BAGB13 (14-fold and 1.6-fold increase with and 
without guanosine supplementation respectively, Fig. 23). The residual 
responsiveness to guanosine supplementation previously observed in BGAB13 
despite PurBoxes mutations and riboswitch engineering is still present in 
BGAB13∆purR despite the additional deletion of purR. This result shows that 
PurR was not responsible for the residual downregulation of LacZ expression 
in response to guanosine supplementation in BGAB13. 
mPB: mutated PurBoxes. eRS: engineered riboswitch. The values represent 
averages ± standard deviations of data obtained from three independent 
cultures. 
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Figure S2. Analysis of B. subtilis transformants generated employing 
the CRISPR-Cas9 system. 
(a) Confirmation of purR deletion using agarose gel electrophoresis. 
(b) Confirmation of pur operon (upper panel) and rib operon (lower panel) 
riboswitches deletions by DNA sequencing of riboswitch regions. 
(c) Confirmation of pur operon (upper panel) and rib operon (lower panel) 
riboswitches editing by DNA sequencing of target regions. 
Chromosomal regions around purR, pur operon riboswitch, and rib operon 
riboswitch were amplified in colony PCR reactions using primers that bind 
outside the homology template sequences. 
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Abbreviations 
5’-UTR 5’ untranslated region 
Amp  Ampicillin 
asRNA Antisense RNA 
B. subtilis Bacillus subtilis 
Cas  CRISPR associated protein 
Cm  Chloramphenicol 
CMM  C minimal medium 
CPEC  Circular Polymerase Extension Cloning 
CRISPR Clustered Regularly Interspaced Short Palindromic Repeats 
crRNA  CRISPR RNA 
tracrRNA trans-activating CRISPR RNA 
DIG  Digoxigenin 
DMSO  Dimethyl sulfoxide 
DNA  Deoxyribonucleic acid 
DTT  Dithiothreitol 
E. coli  Escherichia coli 
EDTA  Ethylenediaminetetraacetic acid 
Abbreviations 
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eRSpur Edited pur operon riboswitch 
eRSrib Edited rib operon riboswitch 
FAD  Flavin adenine dinucleotide 
FMN  Flavin mononucleotide 
GRAS  Generally recognized as safe 
gRNA  Guide RNA 
HPLC  High performance liquid chromatography 
IPTG  Isopropyl β-d-1-thiogalactopyranoside 
Kan  Kanamycin 
LB  Lysogeny broth 
MFE  Minimum free energy 
MOPS  3-(N-morpholino)propanesulfonic acid 
mPB  Mutated PurBoxes 
mRNA  Messenger RNA 
OD  Optical density 
ONPG  Ortho-Nitrophenyl-β-galactoside 
PAM  Protospacer Adjacent Motif 
PCR  Polymerase chain reaction 
RBS  Ribosomal binding site 
Abbreviations 
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RNA  Ribonucleic acid 
RNAP  RNA polymerase 
rNTP  Ribonucleoside tri-phosphate 
RPKM  Reads Per Kilobase of transcript, per Million mapped reads 
rRNA  Ribosomal RNA 
RT  Room temperature 
RT-qPCR Quantitative reverse transcription PCR 
SD  Shine-Dalgarno 
sgRNA Single guide RNA 
Spc  Spectinomycin 
sRNA  Small RNA 
wt  Wild-type 
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